Activation	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
vivo	O
is	O
regulated	O
by	O
multiple	O
phosphorylations	O
.	O

The	O
activation	O
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF-kappa	B-protein
B	I-protein
)	O
in	O
intact	O
cells	O
is	O
mechanistically	O
not	O
well	O
understood	O
.	O

Therefore	O
we	O
investigated	O
the	O
modifications	O
imposed	O
on	O
NF-kappa	B-protein
B/I	I-protein
kappa	I-protein
B	I-protein
components	I-protein
following	O
stimulation	O
and	O
show	O
that	O
the	O
final	O
step	O
of	O
NF-kappa	B-protein
B	I-protein
induction	O
in	O
vivo	O
involves	O
phosphorylation	O
of	O
several	O
members	O
of	O
the	O
NF-kappa	B-protein
B/I	I-protein
kappa	I-protein
B	I-protein
protein	I-protein
families	I-protein
.	O

In	O
HeLa	B-cell_line
cells	I-cell_line
as	O
well	O
as	O
in	O
B	B-cell_type
cells	I-cell_type
,	O
TNF-alpha	O
rapidly	O
induced	O
nuclear	O
translocation	O
primarily	O
of	O
p50-p65	B-protein
,	O
but	O
not	O
of	O
c-rel	B-protein
.	O

Both	O
NF-kappa	B-protein
B	I-protein
precursors	O
and	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
became	O
strongly	O
phosphorylated	O
with	O
the	O
same	O
kinetics	O
.	O

In	O
addition	O
to	O
the	O
inducible	O
phosphorylation	O
after	O
stimulation	O
,	O
B	B-cell_type
lymphocytes	I-cell_type
containing	O
constitutive	O
nuclear	O
NF-kappa	B-protein
B	I-protein
revealed	O
constitutively	O
phosphorylated	O
p65	B-protein
and	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

Phosphorylation	O
was	O
accompanied	O
by	O
induced	O
processing	O
of	O
the	O
precursors	O
p100	B-protein
and	O
p105	B-protein
and	O
by	O
degradation	O
of	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

As	O
an	O
in	O
vitro	O
model	O
we	O
show	O
that	O
phosphorylation	O
of	O
p105	B-protein
impedes	O
its	O
ability	O
to	O
interact	O
with	O
NF-kappa	B-protein
B	I-protein
,	O
as	O
has	O
been	O
shown	O
before	O
for	O
I	B-protein
kappa	I-protein
B	I-protein
alpha	I-protein
.	O

Surprisingly	O
,	O
even	O
p65	B-protein
,	O
but	O
not	O
c-rel	B-protein
,	O
was	O
phosphorylated	O
after	O
induction	O
in	O
vivo	O
,	O
suggesting	O
that	O
TNF-alpha	B-protein
selectively	O
activates	O
only	O
specific	O
NF-kappa	B-protein
B	I-protein
heteromers	O
and	O
that	O
modifications	O
regulate	O
not	O
only	O
I	B-protein
kappa	I-protein
B	I-protein
molecules	I-protein
but	O
also	O
NF-kappa	B-protein
B	I-protein
molecules	O
.	O

In	O
fact	O
,	O
cellular	O
NF-kappa	B-protein
B	I-protein
activity	O
was	O
phosphorylation-dependent	O
and	O
the	O
DNA	O
binding	O
activity	O
of	O
p65-containing	B-protein
NF-kappa	I-protein
B	I-protein
was	O
enhanced	O
by	O
phosphorylation	O
in	O
vitro	O
.	O

Furthermore	O
,	O
we	O
found	O
that	O
the	O
induction	O
by	O
hydrogen	O
peroxide	O
of	O
NF-kappa	B-protein
B	I-protein
translocation	O
to	O
the	O
nucleus	O
,	O
which	O
is	O
assumed	O
to	O
be	O
triggered	O
by	O
reactive	O
oxygen	O
intermediates	O
,	O
also	O
coincided	O
with	O
incorporation	O
of	O
phosphate	O
into	O
the	O
same	O
subunits	O
that	O
were	O
modified	O
after	O
stimulation	O
by	O
TNF-alpha	B-protein
.	O

Thus	O
,	O
phosphorylation	O
appears	O
to	O
be	O
a	O
general	O
mechanism	O
for	O
activation	O
of	O
NF-kappa	B-protein
B	I-protein
in	O
vivo	O
.	O

The	NULL
EMBO	NULL
Journal	NULL
vol.13	NULL
no.19	NULL
pp.4597-4607	NULL
,	NULL
1994	NULL
Activation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
in	NULL
vivo	NULL
is	NULL
regulated	NULL
by	NULL
multiple	NULL
phosphorylations	NULL
Michael	NULL
Naumann	NULL
and	NULL
Claus	NULL
Scheidereit	NULL
'	NULL
Max-Planck-Institut	NULL
fiir	NULL
Molekulare	NULL
Genetik	NULL
,	NULL
Otto-Warburg-Laboratorium	NULL
,	NULL
Thnestrasse	NULL
73	NULL
,	NULL
14195	NULL
Berlin	NULL
(	NULL
Dahlem	NULL
)	NULL
,	NULL
Germany	NULL
'Corresponding	NULL
author	NULL
Communicated	NULL
by	NULL
B.Vennstrom	NULL
The	NULL
activation	NULL
of	NULL
nuclear	NULL
factor	NULL
xB	NULL
(	NULL
NF-xB	NULL
)	NULL
in	NULL
intact	NULL
cells	NULL
is	NULL
mechanistically	NULL
not	NULL
well	NULL
understood	NULL
.	NULL

Therefore	NULL
we	NULL
investigated	NULL
the	NULL
modifications	NULL
imposed	NULL
on	NULL
NF-	NULL
<	NULL
B/	NULL
IxB	NULL
components	NULL
following	NULL
stimulation	NULL
and	NULL
show	NULL
that	NULL
the	NULL
final	NULL
step	NULL
of	NULL
NF-xB	NULL
induction	NULL
in	NULL
vivo	NULL
involves	NULL
phosphorylation	NULL
of	NULL
several	NULL
members	NULL
of	NULL
the	NULL
NF-xB/IxB	NULL
protein	NULL
families	NULL
.	NULL

In	NULL
HeLa	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
TNF-a	NULL
rapidly	NULL
induced	NULL
nuclear	NULL
translocation	NULL
primarily	NULL
of	NULL
p50-p65	NULL
,	NULL
but	NULL
not	NULL
of	NULL
c-rel	NULL
.	NULL

Both	NULL
NF-xB	NULL
precursors	NULL
and	NULL
IxBo	NULL
became	NULL
strongly	NULL
phosphorylated	NULL
with	NULL
the	NULL
same	NULL
kinetics	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
inducible	NULL
phosphorylation	NULL
after	NULL
stimulation	NULL
,	NULL
B	NULL
lymphocytes	NULL
containing	NULL
constitutive	NULL
nuclear	NULL
NF-xB	NULL
-	NULL
revealed	NULL
-	NULL
constitutively	NULL
phosphorylated	NULL
p6S	NULL
and	NULL
IxBo	NULL
.	NULL

Phosphorylation	NULL
was	NULL
accompanied	NULL
by	NULL
induced	NULL
processing	NULL
of	NULL
the	NULL
precursors	NULL
p100	NULL
and	NULL
p105	NULL
and	NULL
by	NULL
degradation	NULL
of	NULL
IxBa	NULL
.	NULL

As	NULL
an	NULL
in	NULL
vitro	NULL
model	NULL
we	NULL
show	NULL
that	NULL
phosphorylation	NULL
of	NULL
p105	NULL
impedes	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
NF-	NULL
<	NULL
B	NULL
,	NULL
as	NULL
has	NULL
been	NULL
shown	NULL
before	NULL
for	NULL
IxBa	NULL
.	NULL

Surprisingly	NULL
,	NULL
even	NULL
p65	NULL
,	NULL
but	NULL
not	NULL
c-rel	NULL
,	NULL
was	NULL
phosphorylated	NULL
after	NULL
induction	NULL
in	NULL
vivo	NULL
,	NULL
suggesting	NULL
that	NULL
TNF-q	NULL
selectively	NULL
activates	NULL
only	NULL
specific	NULL
NF-xB	NULL
heteromers	NULL
and	NULL
that	NULL
modifications	NULL
regulate	NULL
not	NULL
only	NULL
IxB	NULL
molecules	NULL
but	NULL
also	NULL
NF-xB	NULL
molecules	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
cellular	NULL
NF-xB	NULL
activity	NULL
was	NULL
phosphorylation-dependent	NULL
and	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
p65-containing	NULL
NF-xB	NULL
was	NULL
enhanced	NULL
by	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
found	NULL
that	NULL
the	NULL
induction	NULL
by	NULL
hydrogen	NULL
peroxide	NULL
of	NULL
NF-xB	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
which	NULL
is	NULL
assumed	NULL
to	NULL
be	NULL
triggered	NULL
by	NULL
reactive	NULL
oxygen	NULL
inter-mediates	NULL
,	NULL
also	NULL
coincided	NULL
with	NULL
incorporation	NULL
of	NULL
phosphate	NULL
into	NULL
the	NULL
same	NULL
subunits	NULL
that	NULL
were	NULL
modified	NULL
after	NULL
stimulation	NULL
by	NULL
TNF-	NULL
.	NULL

Thus	NULL
,	NULL
phosphorylation	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
general	NULL
mechanism	NULL
for	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
vivo	NULL
.	NULL

Key	NULL
words	NULL
:	NULL
H	NULL
;	NULL
,	NULL
O	NULL
,	NULL
/IKB/NF-KB	NULL
transcription	NULL
factor/pre-cursor/processing/tumor	NULL
necrosis	NULL
factor	NULL
Introduction	NULL
The	NULL
transcription	NULL
factor	NULL
NF-KB	NULL
is	NULL
constitutively	NULL
active	NULL
in	NULL
mature	NULL
B	NULL
lymphocytes	NULL
(	NULL
Sen	NULL
and	NULL
Baltimore	NULL
,	NULL
1986	NULL
;	NULL
Kawakami	NULL
er	NULL
al	NULL
.	NULL

,	NULL
1988	NULL
)	NULL
and	NULL
in	NULL
some	NULL
monocytes/macro-phages	NULL
(	NULL
Griffin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1989	NULL
)	NULL
and	NULL
is	NULL
inducible	NULL
by	NULL
a	NULL
number	NULL
of	NULL
agents	NULL
in	NULL
a	NULL
broad	NULL
spectrum	NULL
of	NULL
cell	NULL
lines	NULL
(	NULL
reviewed	NULL
in	NULL
Lenardo	NULL
and	NULL
Baltimore	NULL
,	NULL
1989	NULL
;	NULL
Baeuerle	NULL
,	NULL
1991	NULL
;	NULL
Blank	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Grilli	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

For	NULL
several	NULL
inducing	NULL
agents	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
a	NULL
©	NULL
Oxford	NULL
University	NULL
Press	NULL
post-translational	NULL
mechanism	NULL
involves	NULL
the	NULL
release	NULL
of	NULL
NF-xB	NULL
from	NULL
cytosolic	NULL
IKB	NULL
proteins	NULL
(	NULL
Baeuerle	NULL
and	NULL
Baltimore	NULL
,	NULL
1988	NULL
)	NULL
.	NULL

NF-xB	NULL
consists	NULL
of	NULL
dimeric	NULL
complexes	NULL
of	NULL
several	NULL
transcription	NULL
factors	NULL
belonging	NULL
to	NULL
a	NULL
family	NULL
whose	NULL
conserved	NULL
members	NULL
include	NULL
the	NULL
re/	NULL
(	NULL
proto	NULL
)	NULL
oncogene	NULL
product	NULL
.	NULL

A	NULL
remarkable	NULL
feature	NULL
of	NULL
NF-KB	NULL
is	NULL
that	NULL
its	NULL
p50	NULL
and	NULL
p52	NULL
subunits	NULL
are	NULL
encoded	NULL
by	NULL
larger	NULL
precursors	NULL
that	NULL
require	NULL
processing	NULL
as	NULL
one	NULL
essential	NULL
activation	NULL
step	NULL
(	NULL
reviewed	NULL
in	NULL
Blank	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
C-terminal	NULL
domains	NULL
of	NULL
the	NULL
precursors	NULL
,	NULL
which	NULL
are	NULL
removed	NULL
after	NULL
processing	NULL
,	NULL
have	NULL
structural	NULL
similarity	NULL
to	NULL
IxBa	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Beg	NULL
and	NULL
Baldwin	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Both	NULL
p105	NULL
(	NULL
NF-xBI1	NULL
,	NULL
the	NULL
precursor	NULL
for	NULL
p50	NULL
)	NULL
and	NULL
p100	NULL
(	NULL
NF-xB2	NULL
,	NULL
the	NULL
precursor	NULL
for	NULL
p52	NULL
)	NULL
,	NULL
form	NULL
cytoplasmic	NULL
complexes	NULL
with	NULL
other	NULL
NF-KB	NULL
subunits	NULL
and	NULL
have	NULL
IKB-like	NULL
functions	NULL
(	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Mercurio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Naumann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
IxBa	NULL
or	NULL
p105	NULL
with	NULL
NF-KB	NULL
subunits	NULL
is	NULL
mediated	NULL
by	NULL
a	NULL
similar	NULL
mechanism	NULL
involving	NULL
ankyrin-like	NULL
repeats	NULL
and	NULL
a	NULL
short	NULL
acidic	NULL
sequence	NULL
(	NULL
Hatada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

These	NULL
structural	NULL
similarities	NULL
suggested	NULL
that	NULL
the	NULL
regulation	NULL
of	NULL
NF-KB	NULL
complexes	NULL
containing	NULL
the	NULL
precursors	NULL
or	NULL
IxBa	NULL
should	NULL
share	NULL
mechanistic	NULL
aspects	NULL
regarding	NULL
their	NULL
activation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
demonstrated	NULL
that	NULL
phosphorylation	NULL
with	NULL
several	NULL
kinases	NULL
leads	NULL
to	NULL
the	NULL
dissociation	NULL
of	NULL
NF-xB-IxB	NULL
complexes	NULL
in	NULL
vitro	NULL
(	NULL
Shirakawa	NULL
and	NULL
Mizel	NULL
,	NULL
1989	NULL
;	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
avian	NULL
IxBa	NULL
is	NULL
a	NULL
phosphoprotein	NULL
and	NULL
its	NULL
interaction	NULL
with	NULL
NF-KB	NULL
can	NULL
be	NULL
blocked	NULL
in	NULL
vitro	NULL
by	NULL
phosphorylation	NULL
with	NULL
PKA	NULL
(	NULL
Kerr	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Human	NULL
IxBa	NULL
is	NULL
inactivated	NULL
by	NULL
phosphorylation	NULL
at	NULL
a	NULL
site	NULL
residing	NULL
in	NULL
the	NULL
repeat	NULL
domain	NULL
(	NULL
D.Krappmann	NULL
and	NULL
C.Scheidereit	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
several	NULL
inducers	NULL
,	NULL
including	NULL
interleukin	NULL
1	NULL
,	NULL
lipopolysaccharide	NULL
(	NULL
LPS	NULL
)	NULL
,	NULL
phorbol	NULL
myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
&	NULL
(	NULL
TNF-	NULL
)	NULL
and	NULL
double-stranded	NULL
RNA	NULL
,	NULL
is	NULL
accompanied	NULL
by	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
Beg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Cordle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Mellits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Sun	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

IxBa	NULL
is	NULL
unstable	NULL
,	NULL
when	NULL
not	NULL
bound	NULL
to	NULL
NF-KB	NULL
,	NULL
as	NULL
demonstrated	NULL
for	NULL
ectopically	NULL
expressed	NULL
IxBa	NULL
(	NULL
Scott	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
and	NULL
is	NULL
rapidly	NULL
turned	NULL
over	NULL
even	NULL
in	NULL
unstimulated	NULL
cells	NULL
(	NULL
Rice	NULL
and	NULL
Emst	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-KB	NULL
seems	NULL
to	NULL
be	NULL
subject	NULL
to	NULL
a	NULL
stimulus-dependent	NULL
proteolysis	NULL
event	NULL
,	NULL
as	NULL
it	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
the	NULL
protease	NULL
inhibitors	NULL
tosylphenylalanine-chloromethyl	NULL
ketone	NULL
(	NULL
TPCK	NULL
)	NULL
or	NULL
tosyl-lysine-chloromethyl	NULL
ketone	NULL
(	NULL
TLCK	NULL
)	NULL
(	NULL
Henkel	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Mellits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
hypothesis	NULL
that	NULL
NF-KB	NULL
is	NULL
directly	NULL
activated	NULL
by	NULL
phosphorylation	NULL
has	NULL
been	NULL
challenged	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
direct	NULL
supportive	NULL
in	NULL
vivo	NULL
data	NULL
and	NULL
by	NULL
recent	NULL
reports	NULL
showing	NULL
that	NULL
NF-KB	NULL
induction	NULL
by	NULL
many	NULL
effectors	NULL
tested	NULL
was	NULL
blocked	NULL
by	NULL
oxygen-radical	NULL
scavenger	NULL
compounds	NULL
and	NULL
that	NULL
hydrogen	NULL
peroxide	NULL
can	NULL
activate	NULL
NF-xB	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
exact	NULL
mechanism	NULL
by	NULL
which	NULL
reactive	NULL
oxygen	NULL
intermediates	NULL
(	NULL
ROIs	NULL
)	NULL
can	NULL
activate	NULL
NF-KB	NULL
remains	NULL
unknown	NULL
.	NULL

4597	NULL
M.Naumann	NULL
and	NULL
C.Scheidereit	NULL
NF-KB	NULL
is	NULL
activated	NULL
by	NULL
TNF-	NULL
,	NULL
a	NULL
fast	NULL
and	NULL
strong	NULL
physiological	NULL
inducer	NULL
,	NULL
at	NULL
a	NULL
post-translational	NULL
level	NULL
,	NULL
but	NULL
also	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
by	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
p105	NULL
and	NULL
p100	NULL
genes	NULL
(	NULL
Hohmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991b	NULL
;	NULL
Meyer	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Mercurio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Ten	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
TNF-	NULL
«	NULL
induces	NULL
transcription	NULL
of	NULL
the	NULL
IxBa	NULL
gene	NULL
(	NULL
de	NULL
Martin	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Le	NULL
Bail	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
rapid	NULL
induction	NULL
of	NULL
NF-KB	NULL
requires	NULL
only	NULL
a	NULL
few	NULL
minutes	NULL
and	NULL
does	NULL
not	NULL
depend	NULL
on	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
Hohmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
proposed	NULL
that	NULL
TNF-	NULL
activates	NULL
NF-KB	NULL
via	NULL
ceramide	NULL
as	NULL
a	NULL
second	NULL
messenger	NULL
(	NULL
Schiitze	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Ceramide	NULL
may	NULL
,	NULL
in	NULL
turn	NULL
,	NULL
activate	NULL
specific	NULL
protein	NULL
kinases	NULL
(	NULL
Dressler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
TNF-a	NULL
increases	NULL
the	NULL
activity	NULL
of	NULL
PKA	NULL
and	NULL
PKC	NULL
(	NULL
Chen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
PKA	NULL
and	NULL
PKC	NULL
seem	NULL
not	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
by	NULL
TNF-a	NULL
in	NULL
HL-60	NULL
or	NULL
Jurkat	NULL
cells	NULL
(	NULL
Feuillard	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Hohmann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991a	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
kinases	NULL
,	NULL
TNF-	NULL
has	NULL
been	NULL
proposed	NULL
to	NULL
induce	NULL
NF-xB	NULL
through	NULL
the	NULL
generation	NULL
of	NULL
ROIs	NULL
(	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
TNF-	NULL
@	NULL
can	NULL
be	NULL
strongly	NULL
reduced	NULL
either	NULL
when	NULL
the	NULL
mitochondrial	NULL
electron	NULL
transfer	NULL
system	NULL
is	NULL
blocked	NULL
by	NULL
chemical	NULL
antagonists	NULL
or	NULL
when	NULL
cells	NULL
lack	NULL
a	NULL
functional	NULL
respiratory	NULL
chain	NULL
(	NULL
Schulze-Osthoff	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
aims	NULL
of	NULL
this	NULL
study	NULL
are	NULL
to	NULL
investigate	NULL
the	NULL
mechanism	NULL
of	NULL
NF-KB	NULL
activation	NULL
in	NULL
vivo	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
HeLa	NULL
cells	NULL
.	NULL

We	NULL
used	NULL
TNF-a	NULL
as	NULL
a	NULL
strong	NULL
and	NULL
fast	NULL
physiological	NULL
inducer	NULL
,	NULL
and	NULL
hydrogen	NULL
peroxide	NULL
,	NULL
which	NULL
activates	NULL
with	NULL
a	NULL
delay	NULL
in	NULL
time	NULL
.	NULL

Our	NULL
data	NULL
demonstrate	NULL
that	NULL
NF-KB	NULL
is	NULL
activated	NULL
by	NULL
a	NULL
mechanism	NULL
involving	NULL
protein	NULL
phosphorylation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
proteolytic	NULL
processes	NULL
.	NULL

Phosphorylation	NULL
appeared	NULL
to	NULL
trigger	NULL
not	NULL
only	NULL
the	NULL
response	NULL
to	NULL
cellular	NULL
inducers	NULL
,	NULL
but	NULL
also	NULL
constitutive	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
We	NULL
found	NULL
that	NULL
there	NULL
are	NULL
different	NULL
levels	NULL
of	NULL
control	NULL
by	NULL
phosphorylation	NULL
.	NULL

After	NULL
stimulation	NULL
,	NULL
the	NULL
p65	NULL
subunit	NULL
of	NULL
NF-KB	NULL
is	NULL
phosphorylated	NULL
and	NULL
exhibits	NULL
strongly	NULL
increased	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
p6S5-associated	NULL
molecules	NULL
p100	NULL
,	NULL
p105	NULL
and	NULL
IxBa	NULL
became	NULL
phosphorylated	NULL
with	NULL
similar	NULL
kinetics	NULL
.	NULL

As	NULL
an	NULL
in	NULL
vitro	NULL
model	NULL
we	NULL
show	NULL
that	NULL
phosphorylation	NULL
with	NULL
PKA	NULL
abrogates	NULL
the	NULL
ability	NULL
of	NULL
p105	NULL
to	NULL
interact	NULL
with	NULL
p65	NULL
,	NULL
but	NULL
enhances	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
p65	NULL
.	NULL

Results	NULL
TNF-	NULL
.	NULL

activates	NULL
NF-	NULL
«	NULL
xB	NULL
by	NULL
inducing	NULL
rapid	NULL
concerted	NULL
processing	NULL
and	NULL
degradation	NULL
events	NULL
,	NULL
involving	NULL
the	NULL
two	NULL
NF-xB	NULL
precursors	NULL
and	NULL
ikkBa	NULL
Both	NULL
the	NULL
precursor	NULL
molecules	NULL
p100	NULL
and	NULL
p105	NULL
,	NULL
and	NULL
IxBa	NULL
form	NULL
cytoplasmic	NULL
complexes	NULL
with	NULL
NF-KB	NULL
proteins	NULL
.	NULL

We	NULL
intended	NULL
to	NULL
investigate	NULL
how	NULL
the	NULL
modification	NULL
state	NULL
and	NULL
the	NULL
stability	NULL
of	NULL
these	NULL
protein	NULL
complexes	NULL
is	NULL
affected	NULL
in	NULL
the	NULL
course	NULL
of	NULL
NF-KB	NULL
activation	NULL
by	NULL
cellular	NULL
stimulation	NULL
.	NULL

Namalwa	NULL
or	NULL
HeLa	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TNF-	NULL
for	NULL
various	NULL
times	NULL
,	NULL
fractionated	NULL
into	NULL
cytoplasmic	NULL
and	NULL
nuclear	NULL
components	NULL
and	NULL
subjected	NULL
to	NULL
Western	NULL
blot	NULL
analysis	NULL
for	NULL
NF-	NULL
«	NULL
B/IxB	NULL
proteins	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

p105	NULL
,	NULL
p100	NULL
and	NULL
IxBa	NULL
were	NULL
observed	NULL
exclusively	NULL
in	NULL
the	NULL
cytoplasm	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
localization	NULL
of	NULL
these	NULL
proteins	NULL
determined	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
labelling	NULL
of	NULL
intact	NULL
cells	NULL
(	NULL
Beg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Naumann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
types	NULL
stimulation	NULL
led	NULL
to	NULL
rapid	NULL
loss	NULL
of	NULL
IxBa	NULL
(	NULL
Figure	NULL
1A	NULL
and	NULL
B	NULL
)	NULL
,	NULL
confirming	NULL
other	NULL
reports	NULL
(	NULL
see	NULL
Introduc-tion	NULL
)	NULL
,	NULL
and	NULL
to	NULL
simultaneous	NULL
processing	NULL
of	NULL
p100	NULL
and	NULL
p105	NULL
4598	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Cellular	NULL
distribution	NULL
of	NULL
NF-KB/rel	NULL
factors	NULL
in	NULL
HeLa	NULL
and	NULL
Namalwa	NULL
cells	NULL
after	NULL
TNF-	NULL
@	NULL
stimulation	NULL
.	NULL

Cytoplasmic	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
(	NULL
25	NULL
ug	NULL
)	NULL
from	NULL
(	NULL
A	NULL
)	NULL
HeLa	NULL
and	NULL
(	NULL
B	NULL
)	NULL
Namalwa	NULL
cells	NULL
were	NULL
prepared	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
analysed	NULL
by	NULL
immunoblotting	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
either	NULL
induced	NULL
with	NULL
TNF-	NULL
(	NULL
10	NULL
or	NULL
40	NULL
min	NULL
)	NULL
or	NULL
left	NULL
untreated	NULL
(	NULL
0	NULL
min	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

The	NULL
different	NULL
panels	NULL
represent	NULL
immunoblots	NULL
performed	NULL
with	NULL
anti-IKBa	NULL
,	NULL
anti-p105N	NULL
,	NULL
anti-p1O0N	NULL
,	NULL
anti-p65	NULL
and	NULL
anti-c-rel	NULL
antisera	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
the	NULL
appropriate	NULL
preimmune	NULL
sera	NULL
(	NULL
C	NULL
)	NULL
were	NULL
used	NULL
.	NULL

TNF-	NULL
a	NULL
10	NULL
4	NULL
TNF-	NULL
a	NULL
[	NULL
T	NULL
I	NULL
j	NULL
®	NULL
e	NULL
e	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

TNF-	NULL
@	NULL
-induced	NULL
nuclear	NULL
NF-KB	NULL
activity	NULL
consists	NULL
primarily	NULL
of	NULL
p50-p65	NULL
,	NULL
whereas	NULL
constitutive	NULL
NF-xB	NULL
is	NULL
composed	NULL
of	NULL
p50-c-rel	NULL
.	NULL

Nuclear	NULL
extracts	NULL
(	NULL
5	NULL
ug	NULL
)	NULL
from	NULL
(	NULL
A	NULL
)	NULL
HeLa	NULL
or	NULL
(	NULL
B	NULL
)	NULL
Namalwa	NULL
cells	NULL
were	NULL
analysed	NULL
in	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
using	NULL
an	NULL
H2-K	NULL
gene	NULL
NF-KB	NULL
binding	NULL
site	NULL
oligoprobe	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
before	NULL
stimulation	NULL
(	NULL
lane	NULL
1	NULL
in	NULL
A	NULL
and	NULL
lanes	NULL
1	NULL
and	NULL
8-11	NULL
in	NULL
B	NULL
)	NULL
or	NULL
after	NULL
10	NULL
min	NULL
(	NULL
lane	NULL
2	NULL
in	NULL
A	NULL
and	NULL
lanes	NULL
2	NULL
and	NULL
4-7	NULL
in	NULL
B	NULL
)	NULL
or	NULL
40	NULL
min	NULL
(	NULL
lanes	NULL
3	NULL
in	NULL
A	NULL
and	NULL
B	NULL
)	NULL
of	NULL
TNF-a	NULL
treatment	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
TNF-	NULL
@	NULL
-induced	NULL
NF-KB	NULL
in	NULL
Namalwa	NULL
cells	NULL
(	NULL
panel	NULL
B	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
was	NULL
investigated	NULL
by	NULL
antibody	NULL
supershifting	NULL
and	NULL
inhibition	NULL
using	NULL
anti-p50	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
anti-p65	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
or	NULL
anti-c-rel	NULL
antisera	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
composition	NULL
of	NULL
constitutive	NULL
NF-xB	NULL
in	NULL
Namalwa	NULL
cells	NULL
(	NULL
B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
was	NULL
analysed	NULL
with	NULL
anti-p65	NULL
,	NULL
anti-c-rel	NULL
or	NULL
anti-p50	NULL
antibodies	NULL
(	NULL
lanes	NULL
8-11	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
in	NULL
panel	NULL
B	NULL
,	NULL
lanes	NULL
1-3	NULL
,	NULL
a	NULL
shorter	NULL
exposure	NULL
is	NULL
shown	NULL
than	NULL
for	NULL
lanes	NULL
4-11	NULL
.	NULL

The	NULL
NF-	NULL
«	NULL
B-DNA	NULL
complex	NULL
is	NULL
indicated	NULL
.	NULL

as	NULL
well	NULL
as	NULL
a	NULL
concomitant	NULL
increase	NULL
of	NULL
the	NULL
processing	NULL
products	NULL
p50	NULL
and	NULL
,	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
p52	NULL
,	NULL
in	NULL
the	NULL
nucleus	NULL
.	NULL

Processing	NULL
of	NULL
p105	NULL
seemed	NULL
to	NULL
be	NULL
more	NULL
efficient	NULL
than	NULL
that	NULL
of	NULL
p100	NULL
.	NULL

Similarly	NULL
,	NULL
p65	NULL
translocated	NULL
to	NULL
the	NULL
nucleus	NULL
,	NULL
correlating	NULL
with	NULL
the	NULL
time	NULL
of	NULL
IxBa	NULL
degradation	NULL
and	NULL
p105	NULL
processing	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
c-rel	NULL
did	NULL
not	NULL
change	NULL
its	NULL
cellular	NULL
distribution	NULL
in	NULL
response	NULL
to	NULL
the	NULL
inducer	NULL
in	NULL
either	NULL
cell	NULL
type	NULL
.	NULL

We	NULL
found	NULL
a	NULL
higher	NULL
constitutive	NULL
amount	NULL
of	NULL
c-rel	NULL
in	NULL
the	NULL
nuclear	NULL
fraction	NULL
of	NULL
B	NULL
cells	NULL
than	NULL
in	NULL
HeLa	NULL
cells	NULL
(	NULL
compare	NULL
Figure	NULL
1A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

The	NULL
correlation	NULL
of	NULL
precursor	NULL
breakdown	NULL
and	NULL
IxBa	NULL
degradation	NULL
with	NULL
nuclear	NULL
translocation	NULL
of	NULL
p50	NULL
or	NULL
p65	NULL
demonstrates	NULL
that	NULL
the	NULL
cytoplasmic	NULL
complexes	NULL
formed	NULL
between	NULL
p100	NULL
,	NULL
p105	NULL
and	NULL
other	NULL
factors	NULL
(	NULL
Rice	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Mercurio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Naumann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
,	NULL
b	NULL
)	NULL
are	NULL
indeed	NULL
subject	NULL
to	NULL
cellular	NULL
regulation	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
c-rel	NULL
was	NULL
not	NULL
affected	NULL
,	NULL
although	NULL
it	NULL
is	NULL
well	NULL
documented	NULL
that	NULL
c-rel	NULL
is	NULL
associated	NULL
with	NULL
p100	NULL
,	NULL
p105	NULL
or	NULL
IxBa	NULL
(	NULL
Mercurio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Rice	NULL
and	NULL
Ernst	NULL
,	NULL
1993	NULL
)	NULL
,	NULL
suggests	NULL
that	NULL
c-rel-containing	NULL
complexes	NULL
can	NULL
not	NULL
be	NULL
directly	NULL
activated	NULL
by	NULL
TNF-a	NULL
.	NULL

This	NULL
also	NULL
indicates	NULL
that	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
factor	NULL
in	NULL
the	NULL
complexes	NULL
with	NULL
IxBa	NULL
molecules	NULL
may	NULL
affect	NULL
a	NULL
recognition	NULL
mechanism	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
.	NULL

The	NULL
observed	NULL
effect	NULL
of	NULL
TNF-	NULL
on	NULL
the	NULL
NF-	NULL
«	NULL
xB/IxB	NULL
system	NULL
is	NULL
the	NULL
same	NULL
in	NULL
B	NULL
cells	NULL
and	NULL
non-B	NULL
cells	NULL
and	NULL
hence	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
general	NULL
mechanism	NULL
.	NULL

The	NULL
observation	NULL
that	NULL
TNF-a	NULL
treatment	NULL
did	NULL
not	NULL
change	NULL
the	NULL
intracellular	NULL
distribution	NULL
of	NULL
c-rel	NULL
tempted	NULL
us	NULL
to	NULL
analyse	NULL
the	NULL
components	NULL
of	NULL
the	NULL
TNF	NULL
--	NULL
induced	NULL
nuclear	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

Even	NULL
before	NULL
induction	NULL
,	NULL
Namalwa	NULL
cells	NULL
displayed	NULL
a	NULL
constitutive	NULL
nuclear	NULL
binding	NULL
activity	NULL
that	NULL
was	NULL
absent	NULL
in	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extracts	NULL
Mechanism	NULL
of	NULL
NF-xB	NULL
activation	NULL
(	NULL
compare	NULL
Figure	NULL
2B	NULL
and	NULL
A	NULL
,	NULL
lanes	NULL
1	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
TNF-	NULL
led	NULL
to	NULL
an	NULL
equivalent	NULL
increase	NULL
of	NULL
NF-KB	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
after	NULL
10	NULL
min	NULL
,	NULL
which	NULL
persisted	NULL
for	NULL
at	NULL
least	NULL
a	NULL
further	NULL
30	NULL
min	NULL
(	NULL
Figure	NULL
2A	NULL
and	NULL
B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

This	NULL
increase	NULL
in	NULL
nuclear	NULL
binding	NULL
activity	NULL
occurred	NULL
when	NULL
the	NULL
amounts	NULL
of	NULL
the	NULL
precursor	NULL
molecules	NULL
and	NULL
of	NULL
IxBa	NULL
declined	NULL
and	NULL
when	NULL
protein	NULL
translocation	NULL
,	NULL
except	NULL
for	NULL
that	NULL
of	NULL
c-rel	NULL
,	NULL
was	NULL
noticed	NULL
(	NULL
see	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

The	NULL
constitutive	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
activity	NULL
seen	NULL
in	NULL
unstimulated	NULL
B-lymphoid	NULL
cells	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
was	NULL
sensitive	NULL
to	NULL
antibodies	NULL
directed	NULL
against	NULL
c-rel	NULL
or	NULL
p50	NULL
(	NULL
lanes	NULL
10	NULL
and	NULL
11	NULL
)	NULL
,	NULL
but	NULL
not	NULL
to	NULL
anti-p65	NULL
antiserum	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
antibodies	NULL
directed	NULL
against	NULL
c-rel	NULL
had	NULL
only	NULL
a	NULL
very	NULL
weak	NULL
effect	NULL
on	NULL
TNF-a	NULL
&	NULL
-induced	NULL
NF-xB	NULL
activity	NULL
(	NULL
Figure	NULL
2B	NULL
,	NULL
compare	NULL
lane	NULL
4	NULL
with	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
which	NULL
was	NULL
strongly	NULL
reduced	NULL
and	NULL
partially	NULL
supershifted	NULL
when	NULL
antibodies	NULL
against	NULL
p50	NULL
or	NULL
p65	NULL
were	NULL
used	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
constitutive	NULL
NF-xB	NULL
activity	NULL
in	NULL
Namalwa	NULL
B	NULL
cells	NULL
consists	NULL
mainly	NULL
of	NULL
p50O-c-rel	NULL
heterodimers	NULL
,	NULL
while	NULL
TNF-a-induced	NULL
NF-xB	NULL
consists	NULL
primarily	NULL
of	NULL
p50-p65	NULL
heterodimers	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
Western	NULL
analysis	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
,	NULL
cytokine	NULL
induction	NULL
does	NULL
not	NULL
induce	NULL
immediate	NULL
translocation	NULL
of	NULL
c-rel	NULL
.	NULL

Surveying	NULL
the	NULL
steady	NULL
state	NULL
amounts	NULL
of	NULL
p105	NULL
and	NULL
IxBa	NULL
by	NULL
Western	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
levels	NULL
of	NULL
these	NULL
proteins	NULL
declined	NULL
rapidly	NULL
after	NULL
cellular	NULL
stimulation	NULL
.	NULL

The	NULL
very	NULL
rapid	NULL
effect	NULL
makes	NULL
it	NULL
very	NULL
unlikely	NULL
that	NULL
induced	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
particularly	NULL
of	NULL
p105	NULL
or	NULL
IxBa	NULL
,	NULL
would	NULL
have	NULL
interfered	NULL
.	NULL

To	NULL
exclude	NULL
this	NULL
possibility	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
pulse-chased	NULL
with	NULL
[	NULL
*°S	NULL
)	NULL
Jmethionine	NULL
and	NULL
then	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
,	NULL
and	NULL
whole-cell	NULL
extracts	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
after	NULL
various	NULL
times	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
,	NULL
an	NULL
antiserum	NULL
directed	NULL
against	NULL
p65	NULL
could	NULL
co-immunoprecipitate	NULL
p105	NULL
,	NULL
p100	NULL
,	NULL
p65	NULL
,	NULL
c-rel	NULL
,	NULL
p50	NULL
and	NULL
IxBa	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
these	NULL
molecules	NULL
was	NULL
proven	NULL
by	NULL
the	NULL
use	NULL
of	NULL
specific	NULL
antibodies	NULL
in	NULL
a	NULL
subsequent	NULL
immunoprecipitation	NULL
(	NULL
Figure	NULL
3A	NULL
,	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
a	NULL
rapid	NULL
decay	NULL
of	NULL
p65-associated	NULL
IxBa	NULL
following	NULL
induction	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

An	NULL
almost	NULL
complete	NULL
disappearance	NULL
of	NULL
IKB	NULL
&	NULL
after	NULL
10	NULL
min	NULL
was	NULL
also	NULL
observed	NULL
when	NULL
total	NULL
cellular	NULL
IKBa	NULL
was	NULL
-	NULL
directly	NULL
-	NULL
precipitated	NULL
-	NULL
from	NULL
-	NULL
TNF-o-stimulated	NULL
,	NULL
[	NULL
*S	NULL
]	NULL
cells	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
both	NULL
precursors	NULL
,	NULL
which	NULL
were	NULL
found	NULL
in	NULL
about	NULL
equal	NULL
amounts	NULL
(	NULL
lanes	NULL
6	NULL
and	NULL
7	NULL
)	NULL
,	NULL
also	NULL
declined	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-	NULL
@	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
confirm	NULL
that	NULL
the	NULL
immediate	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
TNF-	NULL
includes	NULL
induced	NULL
p105	NULL
processing	NULL
,	NULL
cells	NULL
were	NULL
chased	NULL
with	NULL
[	NULL
*°S	NULL
)	NULL
methionine	NULL
,	NULL
induced	NULL
for	NULL
various	NULL
times	NULL
and	NULL
analysed	NULL
by	NULL
immunoprecipitation	NULL
with	NULL
an	NULL
antiserum	NULL
directed	NULL
against	NULL
an	NULL
N-terminal	NULL
peptide	NULL
of	NULL
p105	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

TNF-	NULL
administration	NULL
immediately	NULL
led	NULL
to	NULL
the	NULL
generation	NULL
of	NULL
p50	NULL
(	NULL
compare	NULL
lane	NULL
2	NULL
with	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

In	NULL
cells	NULL
,	NULL
the	NULL
NF-xB	NULL
precursors	NULL
p100	NULL
and	NULL
p105	NULL
,	NULL
as	NULL
well	NULL
as	NULL
p65	NULL
and	NULL
kkBa	NULL
«	NULL
a	NULL
,	NULL
become	NULL
phosphorylated	NULL
with	NULL
similar	NULL
kinetics	NULL
Since	NULL
TNF-	NULL
&	NULL
treatment	NULL
induced	NULL
precursor	NULL
processing	NULL
and	NULL
IxBa	NULL
degradation	NULL
,	NULL
as	NULL
well	NULL
as	NULL
nuclear	NULL
accumulation	NULL
of	NULL
specific	NULL
NF-xB	NULL
proteins	NULL
,	NULL
we	NULL
next	NULL
analysed	NULL
whether	NULL
these	NULL
stimulus-dependent	NULL
alterations	NULL
would	NULL
correlate	NULL
with	NULL
changes	NULL
in	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
these	NULL
proteins	NULL
.	NULL

Extracts	NULL
of	NULL
HeLa	NULL
cells	NULL
with	NULL
incorporated	NULL
[	NULL
*PJortho-phosphate	NULL
were	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
after	NULL
various	NULL
times	NULL
of	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Using	NULL
4599	NULL
M.Naumann	NULL
and	NULL
C.Scheidereit	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

The	NULL
amount	NULL
of	NULL
NF-KB	NULL
precursor	NULL
molecules	NULL
associated	NULL
with	NULL
p65	NULL
decreases	NULL
after	NULL
stimulation	NULL
.	NULL

[	NULL
*°	NULL
$	NULL
]	NULL
methionine-labelled	NULL
HeLa	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
TNF-	NULL
and	NULL
subsequently	NULL
analysed	NULL
by	NULL
immunoprecipitations	NULL
from	NULL
whole	NULL
cell	NULL
extracts	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
TNF-	NULL
@	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
(	NULL
0	NULL
,	NULL
10	NULL
or	NULL
40	NULL
min	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitation	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
anti-p65	NULL
antiserum	NULL
,	NULL
and	NULL
the	NULL
precipitated	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

The	NULL
co-immunoprecipitated	NULL
proteins	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
an	NULL
excess	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
of	NULL
the	NULL
p65-specific	NULL
peptide	NULL
was	NULL
added	NULL
to	NULL
the	NULL
sample	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

After	NULL
the	NULL
first	NULL
immunoprecipitation	NULL
the	NULL
protein	NULL
A	NULL
beads	NULL
were	NULL
centrifuged	NULL
,	NULL
boiled	NULL
and	NULL
diluted	NULL
and	NULL
a	NULL
part	NULL
was	NULL
subjected	NULL
to	NULL
further	NULL
immunoprecipitations	NULL
with	NULL
the	NULL
indicated	NULL
antisera	NULL
(	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

The	NULL
identified	NULL
proteins	NULL
are	NULL
indicated	NULL
with	NULL
small	NULL
black	NULL
dots	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoprecipitation	NULL
with	NULL
an	NULL
antiserum	NULL
against	NULL
an	NULL
N-terminal	NULL
peptide	NULL
of	NULL
p105	NULL
(	NULL
anti-p105N	NULL
)	NULL
.	NULL

Excess	NULL
immunogen	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
cells	NULL
were	NULL
TNF-o-treated	NULL
for	NULL
the	NULL
times	NULL
indicated	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

an	NULL
anti-p65	NULL
antibody	NULL
,	NULL
three	NULL
induced	NULL
phosphorylated	NULL
species	NULL
were	NULL
obtained	NULL
,	NULL
corresponding	NULL
in	NULL
size	NULL
to	NULL
120	NULL
,	NULL
70	NULL
and	NULL
35	NULL
kDa	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
phosphorylated	NULL
species	NULL
have	NULL
been	NULL
precipitated	NULL
with	NULL
the	NULL
p50	NULL
subunit	NULL
(	NULL
Mellits	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

In	NULL
a	NULL
second	NULL
,	NULL
stringent	NULL
precipitation	NULL
the	NULL
phosphorylated	NULL
species	NULL
observed	NULL
in	NULL
the	NULL
first	NULL
step	NULL
were	NULL
unequivocally	NULL
identified	NULL
as	NULL
p100	NULL
,	NULL
p105	NULL
,	NULL
p65	NULL
and	NULL
IxBa	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

No	NULL
phosphorylated	NULL
c-rel	NULL
was	NULL
detected	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
,	NULL
although	NULL
c-rel	NULL
protein	NULL
was	NULL
present	NULL
,	NULL
as	NULL
demonstrated	NULL
by	NULL
precipitation	NULL
with	NULL
p65	NULL
from	NULL
[	NULL
**S	NULL
)	NULL
methionine-labelled	NULL
cells	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
after	NULL
stimulation	NULL
the	NULL
p65	NULL
subunit	NULL
was	NULL
engaged	NULL
in	NULL
complexes	NULL
with	NULL
phosphorylated	NULL
p105	NULL
,	NULL
p100	NULL
or	NULL
IxBa	NULL
(	NULL
and	NULL
non-phosphorylated	NULL
c-rel	NULL
,	NULL
see	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Even	NULL
before	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
there	NULL
was	NULL
a	NULL
weak	NULL
constitutive	NULL
phosphorylation	NULL
of	NULL
p100/p105	NULL
and	NULL
IxBa	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

The	NULL
TNF-	NULL
treatment	NULL
then	NULL
caused	NULL
a	NULL
strong	NULL
increase	NULL
in	NULL
the	NULL
phosphorylation	NULL
of	NULL
the	NULL
precursors	NULL
,	NULL
of	NULL
IxBa	NULL
and	NULL
,	NULL
most	NULL
notably	NULL
,	NULL
of	NULL
p65	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

It	NULL
should	NULL
be	NULL
recalled	NULL
that	NULL
at	NULL
the	NULL
same	NULL
time	NULL
point	NULL
the	NULL
levels	NULL
of	NULL
proteins	NULL
,	NULL
particularly	NULL
of	NULL
p105	NULL
,	NULL
p100	NULL
and	NULL
IxBa	NULL
,	NULL
were	NULL
already	NULL
strongly	NULL
4600	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Similar	NULL
kinetics	NULL
of	NULL
inducible	NULL
phosphorylation	NULL
were	NULL
observed	NULL
for	NULL
the	NULL
NF-KB	NULL
precursors	NULL
,	NULL
for	NULL
p65	NULL
and	NULL
for	NULL
IxBa	NULL
.	NULL

HeLa	NULL
cells	NULL
were	NULL
labelled	NULL
with	NULL
and	NULL
whole	NULL
cell	NULL
extracts	NULL
were	NULL
prepared	NULL
before	NULL
or	NULL
after	NULL
induction	NULL
with	NULL
TNF-	NULL
@	NULL
(	NULL
0	NULL
,	NULL
10	NULL
or	NULL
40	NULL
min	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitation	NULL
with	NULL
an	NULL
anti-p65	NULL
antiserum	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
p65	NULL
peptide	NULL
,	NULL
which	NULL
was	NULL
used	NULL
to	NULL
raise	NULL
the	NULL
antibody	NULL
,	NULL
was	NULL
added	NULL
to	NULL
the	NULL
samples	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

A	NULL
subsequent	NULL
immunoprecipitation	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
indicated	NULL
antisera	NULL
to	NULL
prove	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
co-immunoprecipitated	NULL
molecules	NULL
(	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

The	NULL
identified	NULL
proteins	NULL
are	NULL
indicated	NULL
by	NULL
small	NULL
black	NULL
dots	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Immunoprecipitation	NULL
with	NULL
an	NULL
anti-p105C	NULL
antiserum	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
the	NULL
preimmune	NULL
serum	NULL
was	NULL
used	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunoprecipitation	NULL
with	NULL
an	NULL
anti-p100C	NULL
antiserum	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
.	NULL

The	NULL
control	NULL
is	NULL
a	NULL
precipitation	NULL
with	NULL
the	NULL
preimmune	NULL
serum	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

diminished	NULL
(	NULL
Figures	NULL
1	NULL
and	NULL
3	NULL
)	NULL
,	NULL
which	NULL
demonstrates	NULL
the	NULL
drastic	NULL
increase	NULL
of	NULL
phosphorylation	NULL
of	NULL
the	NULL
single	NULL
molecules	NULL
.	NULL

Based	NULL
on	NULL
the	NULL
same	NULL
reasoning	NULL
,	NULL
the	NULL
signal-dependent	NULL
specific	NULL
phosphorylation	NULL
of	NULL
the	NULL
precursor	NULL
molecules	NULL
and	NULL
of	NULL
IxBa	NULL
appears	NULL
to	NULL
be	NULL
higher	NULL
than	NULL
that	NULL
of	NULL
p65	NULL
.	NULL

After	NULL
longer	NULL
exposure	NULL
to	NULL
TNF-	NULL
the	NULL
levels	NULL
of	NULL
phosphoproteins	NULL
declined	NULL
again	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
paralleled	NULL
by	NULL
a	NULL
further	NULL
loss	NULL
of	NULL
the	NULL
precursor	NULL
and	NULL
IxBa	NULL
proteins	NULL
(	NULL
Figure	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

Whereas	NULL
radiolabelled	NULL
p105	NULL
and	NULL
p100	NULL
could	NULL
be	NULL
precipitated	NULL
with	NULL
p65	NULL
,	NULL
no	NULL
phosphorylated	NULL
p50	NULL
or	NULL
p52	NULL
was	NULL
detected	NULL
.	NULL

The	NULL
simplest	NULL
explanation	NULL
is	NULL
that	NULL
both	NULL
precursors	NULL
were	NULL
phosphorylated	NULL
in	NULL
their	NULL
C-terminal	NULL
domains	NULL
,	NULL
which	NULL
were	NULL
lost	NULL
after	NULL
processing	NULL
.	NULL

This	NULL
would	NULL
explain	NULL
why	NULL
no	NULL
labelled	NULL
p50	NULL
or	NULL
p52	NULL
was	NULL
obtained	NULL
after	NULL
processing	NULL
.	NULL

This	NULL
experiment	NULL
clearly	NULL
demonstrates	NULL
that	NULL
precursor	NULL
processing	NULL
and	NULL
IxBa	NULL
degradation	NULL
are	NULL
preceded	NULL
by	NULL
or	NULL
accompanied	NULL
by	NULL
a	NULL
phosphorylation	NULL
event	NULL
,	NULL
and	NULL
it	NULL
suggests	NULL
that	NULL
phosphorylated	NULL
p100	NULL
,	NULL
p105	NULL
and	NULL
IB	NULL
can	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
still	NULL
interact	NULL
with	NULL
p65	NULL
.	NULL

It	NULL
is	NULL
difficult	NULL
to	NULL
estimate	NULL
the	NULL
absolute	NULL
amounts	NULL
of	NULL
phosphorylated	NULL
protein	NULL
and	NULL
hence	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
only	NULL
a	NULL
fraction	NULL
of	NULL
the	NULL
phosphorylated	NULL
proteins	NULL
are	NULL
associated	NULL
with	NULL
p65	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
p65	NULL
itself	NULL
was	NULL
found	NULL
to	NULL
be	NULL
the	NULL
target	NULL
of	NULL
signal-dependent	NULL
modification	NULL
.	NULL

Because	NULL
both	NULL
precursors	NULL
were	NULL
phosphorylated	NULL
and	NULL
co-precipitated	NULL
with	NULL
p65	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
we	NULL
next	NULL
addressed	NULL
the	NULL
question	NULL
of	NULL
whether	NULL
their	NULL
modification	NULL
occurred	NULL
with	NULL
the	NULL
same	NULL
or	NULL
with	NULL
distinct	NULL
kinetics	NULL
.	NULL

Therefore	NULL
,	NULL
HeLa	NULL
cells	NULL
were	NULL
labelled	NULL
with	NULL
[	NULL
°PJorthophosphate	NULL
,	NULL
treated	NULL
with	NULL
TNF-a	NULL
for	NULL
various	NULL
times	NULL
and	NULL
subjected	NULL
to	NULL
immunoprecipitation	NULL
using	NULL
antibodies	NULL
specific	NULL
for	NULL
either	NULL
p105	NULL
or	NULL
p100	NULL
(	NULL
Figure	NULL
4B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

The	NULL
two	NULL
precursor	NULL
molecules	NULL
showed	NULL
indistinguishable	NULL
time-courses	NULL
,	NULL
with	NULL
phosphorylation	NULL
peaking	NULL
10	NULL
min	NULL
after	NULL
administration	NULL
of	NULL
the	NULL
inducer	NULL
(	NULL
Figure	NULL
4B	NULL
and	NULL
C	NULL
,	NULL
lanes	NULL
2-4	NULL
)	NULL
,	NULL
suggesting	NULL
an	NULL
identical	NULL
modification	NULL
event	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
similar	NULL
fraction	NULL
of	NULL
both	NULL
p105	NULL
and	NULL
p100	NULL
was	NULL
phosphorylated	NULL
even	NULL
before	NULL
stimulation	NULL
(	NULL
Figure	NULL
4B	NULL
and	NULL
C	NULL
,	NULL
lanes	NULL
2	NULL
)	NULL
.	NULL

It	NULL
is	NULL
thus	NULL
likely	NULL
that	NULL
the	NULL
same	NULL
kinase	NULL
phosphorylates	NULL
p100	NULL
and	NULL
p105	NULL
and	NULL
,	NULL
given	NULL
the	NULL
similar	NULL
incorporation	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
for	NULL
the	NULL
approximately	NULL
equal	NULL
protein	NULL
amounts	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
,	NULL
it	NULL
is	NULL
even	NULL
possible	NULL
that	NULL
the	NULL
phosphorylation	NULL
site	NULL
is	NULL
conserved	NULL
in	NULL
the	NULL
two	NULL
precursors	NULL
.	NULL

TNF-o-mediated	NULL
activation	NULL
of	NULL
NF-xB	NULL
in	NULL
B	NULL
cells	NULL
B	NULL
cells	NULL
contain	NULL
a	NULL
constitutive	NULL
nuclear	NULL
NF-KB	NULL
activity	NULL
,	NULL
indicating	NULL
that	NULL
a	NULL
mechanism	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
operates	NULL
constitutively	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Yet	NULL
the	NULL
response	NULL
to	NULL
TNF-	NULL
«	NULL
treatment	NULL
resembled	NULL
that	NULL
of	NULL
HeLa	NULL
cells	NULL
with	NULL
a	NULL
similar	NULL
breakdown	NULL
of	NULL
the	NULL
precursors	NULL
and	NULL
of	NULL
IxBa	NULL
at	NULL
the	NULL
same	NULL
time	NULL
point	NULL
after	NULL
stimulation	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

Striking	NULL
differences	NULL
from	NULL
HeLa	NULL
cells	NULL
were	NULL
observed	NULL
when	NULL
analysing	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
NF-xB/IxB	NULL
proteins	NULL
associated	NULL
with	NULL
p65	NULL
after	NULL
stimulation	NULL
in	NULL
Namalwa	NULL
cells	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

After	NULL
these	NULL
cells	NULL
had	NULL
been	NULL
labelled	NULL
with	NULL
[	NULL
*P	NULL
a	NULL
coprecipitation	NULL
experiment	NULL
with	NULL
an	NULL
anti-p65	NULL
antibody	NULL
revealed	NULL
that	NULL
p105	NULL
,	NULL
p100	NULL
,	NULL
p65	NULL
and	NULL
IxB-	NULL
&	NULL
were	NULL
phosphorylated	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
1-3	NULL
)	NULL
,	NULL
as	NULL
observed	NULL
already	NULL
for	NULL
Hela	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
single	NULL
proteins	NULL
was	NULL
again	NULL
proven	NULL
by	NULL
a	NULL
second	NULL
precipitation	NULL
with	NULL
specific	NULL
antibodies	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

A	NULL
fainter	NULL
band	NULL
migrated	NULL
with	NULL
the	NULL
mobility	NULL
expected	NULL
for	NULL
c-rel	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
but	NULL
could	NULL
not	NULL
be	NULL
detected	NULL
after	NULL
the	NULL
second	NULL
precipitation	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
remarkable	NULL
contrast	NULL
to	NULL
HeLa	NULL
cells	NULL
,	NULL
IxBa	NULL
was	NULL
observed	NULL
as	NULL
two	NULL
differently	NULL
migrating	NULL
forms	NULL
which	NULL
were	NULL
already	NULL
strongly	NULL
phosphorylated	NULL
before	NULL
stimulation	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

After	NULL
stimulation	NULL
the	NULL
faster	NULL
form	NULL
became	NULL
fainter	NULL
,	NULL
while	NULL
the	NULL
other	NULL
form	NULL
displayed	NULL
enhanced	NULL
phosphorylation	NULL
which	NULL
did	NULL
not	NULL
decline	NULL
after	NULL
stimulation	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
decrease	NULL
observed	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Similarly	NULL
,	NULL
both	NULL
precursor	NULL
proteins	NULL
were	NULL
constitutively	NULL
phosphorylated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

After	NULL
stimulation	NULL
a	NULL
continuous	NULL
increase	NULL
of	NULL
phosphorylation	NULL
was	NULL
observed	NULL
for	NULL
proteins	NULL
in	NULL
the	NULL
size	NULL
range	NULL
100-120	NULL
kDa	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

The	NULL
same	NULL
phenomenon	NULL
was	NULL
observed	NULL
for	NULL
p65	NULL
,	NULL
which	NULL
was	NULL
phosphorylated	NULL
constitu-	NULL
Mechanism	NULL
of	NULL
NF-xB	NULL
activation	NULL
L	NULL
C	NULL
2nd	NULL
precipitation	NULL
¢	NULL
®	NULL
O	NULL
a	NULL
&	NULL
-S	NULL
``	NULL
.g	NULL
G	NULL
LP	NULL
@	NULL
C	NULL
A	NULL
Q3	NULL
0	NULL
'	NULL
40	NULL
N	NULL
G°	NULL
14	NULL
%	NULL
fd	NULL
1°	NULL
208	NULL
5	NULL
6	NULL
8s	NULL
9	NULL
5	NULL
le	NULL
2nd	NULL
precipitation	NULL
$	NULL
.s	NULL
AV	NULL
1	NULL
2	NULL
3	NULL
5	NULL
6	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

The	NULL
NF-xB	NULL
precursors	NULL
,	NULL
p65	NULL
and	NULL
IxBa	NULL
are	NULL
constitutively	NULL
phosphorylated	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Namalwa	NULL
cells	NULL
were	NULL
labelled	NULL
with	NULL
[	NULL
32P	NULL
]	NULL
onhophosphate	NULL
and	NULL
induced	NULL
with	NULL
TNF-q	NULL
in	NULL
the	NULL
same	NULL
manner	NULL
as	NULL
HeLa	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Immunoprecipitation	NULL
from	NULL
whole	NULL
cell	NULL
extracts	NULL
with	NULL
an	NULL
anti-p65	NULL
antiserum	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
p65	NULL
peptide	NULL
antigen	NULL
was	NULL
added	NULL
to	NULL
the	NULL
sample	NULL
beforehand	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

The	NULL
pellets	NULL
were	NULL
solubilized	NULL
and	NULL
a	NULL
part	NULL
re-precipitated	NULL
with	NULL
the	NULL
indicated	NULL
antisera	NULL
,	NULL
to	NULL
prove	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
co-immunoprecipitated	NULL
molecules	NULL
(	NULL
lanes	NULL
5-9	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Precipitation	NULL
with	NULL
the	NULL
anti-p105C	NULL
antiserum	NULL
(	NULL
lanes	NULL
1-3	NULL
)	NULL
and	NULL
with	NULL
the	NULL
preimmune	NULL
serum	NULL
as	NULL
a	NULL
control	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

A	NULL
subsequent	NULL
re-precipitation	NULL
was	NULL
performed	NULL
with	NULL
antibodies	NULL
against	NULL
p65	NULL
or	NULL
p105	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
An	NULL
anti-p100C	NULL
antiserum	NULL
was	NULL
used	NULL
for	NULL
p100	NULL
co-immunoprecipitations	NULL
(	NULL
lanes	NULL
2-4	NULL
)	NULL
with	NULL
the	NULL
preimmune	NULL
serum	NULL
as	NULL
a	NULL
control	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

Further	NULL
immunoprecipitations	NULL
were	NULL
performed	NULL
from	NULL
the	NULL
first	NULL
solubilized	NULL
precipitate	NULL
with	NULL
anti-p65	NULL
or	NULL
anti-p100C	NULL
antiserum	NULL
,	NULL
respectively	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
immunoprecipitated	NULL
proteins	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

Identified	NULL
proteins	NULL
from	NULL
the	NULL
second	NULL
immunoprecipitations	NULL
are	NULL
indicated	NULL
by	NULL
small	NULL
black	NULL
dots	NULL
.	NULL

tively	NULL
,	NULL
in	NULL
striking	NULL
contrast	NULL
to	NULL
HeLa	NULL
cells	NULL
(	NULL
compare	NULL
Figure	NULL
4A	NULL
,	NULL
lane	NULL
2	NULL
,	NULL
with	NULL
Figure	NULL
5A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
.	NULL

No	NULL
difference	NULL
in	NULL
TNF-a-dependent	NULL
phosphorylation	NULL
was	NULL
seen	NULL
for	NULL
p105	NULL
and	NULL
p100	NULL
,	NULL
both	NULL
of	NULL
which	NULL
were	NULL
already	NULL
constitutively	NULL
phosphorylated	NULL
(	NULL
Figure	NULL
5B	NULL
and	NULL
C	NULL
)	NULL
.	NULL

We	NULL
also	NULL
established	NULL
that	NULL
there	NULL
is	NULL
very	NULL
little	NULL
,	NULL
if	NULL
any	NULL
,	NULL
phosphorylated	NULL
c-rel	NULL
after	NULL
stimulation	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Figure	NULL
5A	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

p65	NULL
co-immunoprecititated	NULL
with	NULL
another	NULL
phosphorylated	NULL
protein	NULL
running	NULL
below	NULL
the	NULL
p105/p100	NULL
signal	NULL
(	NULL
which	NULL
migrates	NULL
at	NULL
~115-120	NULL
kDa	NULL
)	NULL
(	NULL
Figure	NULL
5A	NULL
)	NULL
.	NULL

We	NULL
do	NULL
not	NULL
know	NULL
yet	NULL
whether	NULL
this	NULL
species	NULL
is	NULL
a	NULL
degradation	NULL
product	NULL
of	NULL
p100	NULL
or	NULL
p105	NULL
or	NULL
whether	NULL
it	NULL
represents	NULL
a	NULL
newly	NULL
discovered	NULL
interacting	NULL
4601	NULL
M.Naumann	NULL
and	NULL
C.Scheidereit	NULL
polypeptide	NULL
.	NULL

We	NULL
did	NULL
observe	NULL
a	NULL
protein	NULL
in	NULL
this	NULL
size	NULL
range	NULL
,	NULL
but	NULL
distinct	NULL
from	NULL
p100	NULL
and	NULL
p105	NULL
,	NULL
which	NULL
was	NULL
associated	NULL
with	NULL
p65	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

It	NULL
is	NULL
important	NULL
that	NULL
p65	NULL
is	NULL
constitutively	NULL
phosphorylated	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
HeLa	NULL
cells	NULL
it	NULL
is	NULL
detected	NULL
as	NULL
a	NULL
phosphoprotein	NULL
only	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
.	NULL

This	NULL
may	NULL
indicate	NULL
that	NULL
in	NULL
Namalwa	NULL
cells	NULL
there	NULL
is	NULL
a	NULL
constitutively	NULL
active	NULL
kinase	NULL
,	NULL
which	NULL
has	NULL
to	NULL
be	NULL
activated	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
the	NULL
high	NULL
constitutive	NULL
phosphorylation	NULL
both	NULL
of	NULL
IxBa	NULL
and	NULL
of	NULL
the	NULL
precursor	NULL
proteins	NULL
in	NULL
B	NULL
cells	NULL
suggests	NULL
that	NULL
the	NULL
constitutive	NULL
NF-KB	NULL
activity	NULL
in	NULL
these	NULL
cells	NULL
is	NULL
due	NULL
to	NULL
an	NULL
increased	NULL
turnover	NULL
of	NULL
the	NULL
precursors	NULL
and	NULL
of	NULL
IxBa	NULL
following	NULL
continuous	NULL
phosphorylation	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
this	NULL
,	NULL
a	NULL
faster	NULL
turnover	NULL
of	NULL
IKBa	NULL
in	NULL
B	NULL
cells	NULL
has	NULL
also	NULL
been	NULL
noted	NULL
by	NULL
Rice	NULL
and	NULL
Ernst	NULL
(	NULL
1993	NULL
)	NULL
.	NULL

Fast	NULL
and	NULL
continuous	NULL
turnover	NULL
of	NULL
IxBa	NULL
in	NULL
B	NULL
cells	NULL
may	NULL
explain	NULL
why	NULL
radiolabelled	NULL
IxBa	NULL
is	NULL
observed	NULL
after	NULL
stimulation	NULL
for	NULL
40	NULL
min	NULL
in	NULL
Figure	NULL
5A	NULL
,	NULL
although	NULL
the	NULL
total	NULL
amounts	NULL
of	NULL
IB	NULL
protein	NULL
were	NULL
strongly	NULL
decreased	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

Presumably	NULL
the	NULL
constantly	NULL
de	NULL
novo	NULL
translated	NULL
protein	NULL
is	NULL
immediately	NULL
phosphorylated	NULL
and	NULL
degraded	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
signal	NULL
and	NULL
the	NULL
difference	NULL
from	NULL
HeLa	NULL
cells	NULL
just	NULL
reflects	NULL
the	NULL
high	NULL
turnover	NULL
of	NULL
IxBa	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Inducible	NULL
phosphorylation	NULL
appears	NULL
to	NULL
be	NULL
a	NULL
general	NULL
activation	NULL
mechanism	NULL
for	NULL
NF-xB	NULL
Next	NULL
,	NULL
we	NULL
asked	NULL
whether	NULL
phosphorylation	NULL
of	NULL
components	NULL
of	NULL
the	NULL
NF-xB/IxB	NULL
system	NULL
would	NULL
be	NULL
a	NULL
general	NULL
in	NULL
vivo	NULL
mechanism	NULL
accompanied	NULL
by	NULL
the	NULL
release	NULL
of	NULL
active	NULL
from	NULL
its	NULL
inhibitory	NULL
cytoplasmic	NULL
structures	NULL
and	NULL
whether	NULL
inducers	NULL
other	NULL
than	NULL
cytokines	NULL
would	NULL
utilize	NULL
the	NULL
same	NULL
modification	NULL
.	NULL

ROIs	NULL
have	NULL
been	NULL
proposed	NULL
to	NULL
be	NULL
potential	NULL
intracellular	NULL
messengers	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
NF-KB	NULL
and	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
hydrogen	NULL
peroxide	NULL
activates	NULL
NF-xB	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Extracellular	NULL
exposure	NULL
of	NULL
HeLa	NULL
cells	NULL
to	NULL
hydrogen	NULL
peroxide	NULL
led	NULL
to	NULL
the	NULL
expected	NULL
nuclear	NULL
accumulation	NULL
of	NULL
NF-xB	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

Surprisingly	NULL
,	NULL
immunoprecipitation	NULL
with	NULL
anti-p65	NULL
antibodies	NULL
revealed	NULL
that	NULL
NF-KB	NULL
induction	NULL
was	NULL
again	NULL
paralleled	NULL
by	NULL
phosphorylation	NULL
of	NULL
the	NULL
NF-KB	NULL
precursors	NULL
,	NULL
of	NULL
p65	NULL
and	NULL
of	NULL
IxBa	NULL
(	NULL
Figure	NULL
6B	NULL
,	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
,	NULL
as	NULL
observed	NULL
for	NULL
the	NULL
rapid	NULL
induction	NULL
by	NULL
TNF-a	NULL
.	NULL

It	NULL
is	NULL
striking	NULL
that	NULL
the	NULL
same	NULL
subunits	NULL
were	NULL
modified	NULL
and	NULL
that	NULL
p50	NULL
,	NULL
p52	NULL
,	NULL
c-rel	NULL
and	NULL
other	NULL
components	NULL
were	NULL
not	NULL
phosphorylated	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
cellular	NULL
stimulation	NULL
by	NULL
TNF-	NULL
or	NULL
hydrogen	NULL
peroxide	NULL
on	NULL
NF-KxB/IxB	NULL
are	NULL
summarized	NULL
in	NULL
Table	NULL
I	NULL
.	NULL

We	NULL
have	NULL
also	NULL
found	NULL
that	NULL
NF-KB	NULL
induction	NULL
by	NULL
phorbol	NULL
ester	NULL
(	NULL
PMA	NULL
)	NULL
similarly	NULL
coincides	NULL
with	NULL
phosphorylation	NULL
in	NULL
vivo	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

For	NULL
all	NULL
different	NULL
inducers	NULL
tested	NULL
,	NULL
phosphorylation	NULL
always	NULL
occurred	NULL
at	NULL
the	NULL
time	NULL
of	NULL
nuclear	NULL
translocation	NULL
,	NULL
no	NULL
matter	NULL
how	NULL
fast	NULL
the	NULL
induction	NULL
was	NULL
.	NULL

This	NULL
may	NULL
hint	NULL
at	NULL
convergent	NULL
pathways	NULL
and	NULL
at	NULL
the	NULL
involvement	NULL
of	NULL
perhaps	NULL
only	NULL
one	NULL
or	NULL
very	NULL
few	NULL
kinases	NULL
which	NULL
finally	NULL
activate	NULL
NF-KB	NULL
.	NULL

Nuclear	NULL
NF-xB	NULL
is	NULL
phosphorylated	NULL
at	NULL
the	NULL
p65	NULL
subunit	NULL
,	NULL
leading	NULL
to	NULL
enhanced	NULL
DNA	NULL
binding	NULL
The	NULL
striking	NULL
observation	NULL
that	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
subunit	NULL
becomes	NULL
phosphorylated	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-	NULL
or	NULL
hydrogen	NULL
peroxide	NULL
and	NULL
is	NULL
constitutively	NULL
phosphorylated	NULL
in	NULL
B	NULL
cells	NULL
tempted	NULL
us	NULL
to	NULL
analyse	NULL
the	NULL
effect	NULL
of	NULL
phosphorylation	NULL
on	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

The	NULL
nuclear	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
activity	NULL
,	NULL
which	NULL
consisted	NULL
mainly	NULL
of	NULL
4602	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

NF-KB	NULL
induction	NULL
by	NULL
H	NULL
,	NULL
O	NULL
;	NULL
involves	NULL
transfer	NULL
of	NULL
phosphoryl	NULL
groups	NULL
onto	NULL
p105/p100	NULL
,	NULL
p65	NULL
and	NULL
IxBa	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
of	NULL
HeLa	NULL
cells	NULL
which	NULL
were	NULL
either	NULL
untreated	NULL
or	NULL
stimulated	NULL
with	NULL
250	NULL
uM	NULL
H	NULL
,	NULL
O	NULL
;	NULL
for	NULL
70	NULL
min	NULL
were	NULL
assayed	NULL
by	NULL
EMSA	NULL
.	NULL

(	NULL
B	NULL
)	NULL
HeLa	NULL
cells	NULL
were	NULL
labelled	NULL
with	NULL
[	NULL
*P	NULL
Jorthophosphate	NULL
.	NULL

Subsequently	NULL
,	NULL
immunoprecipitations	NULL
were	NULL
performed	NULL
from	NULL
whole	NULL
cell	NULL
extracts	NULL
before	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
after	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
incubation	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
250	NULL
uM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
for	NULL
70	NULL
min	NULL
using	NULL
the	NULL
anti-p65	NULL
antibody	NULL
.	NULL

In	NULL
lane	NULL
1	NULL
,	NULL
the	NULL
peptide	NULL
antigen	NULL
was	NULL
added	NULL
as	NULL
a	NULL
control	NULL
.	NULL

heterodimers	NULL
containing	NULL
p65	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
was	NULL
therefore	NULL
tested	NULL
for	NULL
sensitivity	NULL
to	NULL
phosphatases	NULL
(	NULL
Figure	NULL
7A	NULL
)	NULL
.	NULL

Interest-ingly	NULL
,	NULL
treatment	NULL
with	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
potato	NULL
acid	NULL
phosphatase	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
strongly	NULL
reduced	NULL
the	NULL
TNF-	NULL
«	NULL
-induced	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
heat-inactivated	NULL
phosphatase	NULL
had	NULL
no	NULL
effect	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

To	NULL
rule	NULL
out	NULL
indirect	NULL
effects	NULL
of	NULL
the	NULL
phosphatases	NULL
,	NULL
p65-containing	NULL
NF-xB	NULL
was	NULL
purified	NULL
from	NULL
a	NULL
nuclear	NULL
extract	NULL
of	NULL
TNF-o-stimulated	NULL
HeLa	NULL
cells	NULL
with	NULL
an	NULL
anti-p65	NULL
antibody	NULL
column	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
purified	NULL
NF-KB	NULL
(	NULL
Figure	NULL
7B	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
was	NULL
again	NULL
reduced	NULL
by	NULL
treatment	NULL
with	NULL
phosphatase	NULL
but	NULL
not	NULL
by	NULL
heat-inactivated	NULL
phosphatase	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NF-KB	NULL
subunits	NULL
can	NULL
be	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
and	NULL
whether	NULL
they	NULL
can	NULL
display	NULL
different	NULL
DNA	NULL
binding	NULL
properties	NULL
,	NULL
we	NULL
used	NULL
PKA	NULL
and	NULL
PKC	NULL
as	NULL
modifying	NULL
kinases	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7C	NULL
,	NULL
p105	NULL
was	NULL
efficiently	NULL
labelled	NULL
by	NULL
PKA	NULL
and	NULL
p100	NULL
less	NULL
efficiently	NULL
labelled	NULL
,	NULL
whereas	NULL
their	NULL
processing	NULL
products	NULL
,	NULL
p50	NULL
and	NULL
p52	NULL
,	NULL
were	NULL
refractory	NULL
to	NULL
modification	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
with	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
)	NULL
.	NULL

p65	NULL
was	NULL
also	NULL
efficiently	NULL
phosphorylated	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

Similar	NULL
data	NULL
were	NULL
obtained	NULL
using	NULL
PKC	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
results	NULL
are	NULL
also	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
isolated	NULL
C-terminal	NULL
precursor	NULL
domain	NULL
(	NULL
Hatada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
can	NULL
be	NULL
phosphorylated	NULL
by	NULL
both	NULL
PKA	NULL
and	NULL
PKC	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
7D	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
with	NULL
recombinant	NULL
proteins	NULL
,	NULL
DNA	NULL
binding	NULL
of	NULL
p50	NULL
is	NULL
unaffected	NULL
by	NULL
phosphoryl	NULL
Mechanism	NULL
of	NULL
NF-xB	NULL
activation	NULL
Table	NULL
I.	NULL
Alterations	NULL
imposed	NULL
on	NULL
NF-KB/IxB	NULL
proteins	NULL
following	NULL
cellular	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
or	NULL
H	NULL
,	NULL
O	NULL
;	NULL
p105	NULL
p100	NULL
p50	NULL
p52	NULL
p6S	NULL
c-rel	NULL
IxBa	NULL
Association	NULL
with	NULL
p65	NULL
Phosphorylation	NULL
``	NULL
Constitutive	NULL
phosphorylation	NULL
in	NULL
B	NULL
cells	NULL
Processing	NULL
Degradation	NULL
Nuclear	NULL
translocation	NULL
Io	NULL
+++	NULL
+	NULL
ce	NULL
+	NULL
oI	NULL
1	NULL
+	NULL
+3	NULL
)	NULL
``	NULL
Phosphorylation	NULL
was	NULL
observed	NULL
for	NULL
p6S-associated	NULL
proteins	NULL
and	NULL
also	NULL
for	NULL
total	NULL
p100	NULL
,	NULL
p105	NULL
,	NULL
or	NULL
IxBa	NULL
(	NULL
Figure	NULL
4	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

For	NULL
H	NULL
,	NULL
O	NULL
;	NULL
only	NULL
phosphorylation	NULL
data	NULL
are	NULL
shown	NULL
.	NULL

ation	NULL
with	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
whereas	NULL
p65	NULL
homodimers	NULL
or	NULL
p50-p65	NULL
heterodimers	NULL
displayed	NULL
increased	NULL
DNA	NULL
binding	NULL
activity	NULL
upon	NULL
phosphorylation	NULL
(	NULL
compare	NULL
lane	NULL
3	NULL
with	NULL
lane	NULL
4	NULL
and	NULL
lane	NULL
5	NULL
with	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
phosphorylation	NULL
on	NULL
p65	NULL
by	NULL
PKA	NULL
in	NULL
vitro	NULL
may	NULL
mimic	NULL
a	NULL
cellular	NULL
kinase	NULL
which	NULL
may	NULL
interact	NULL
with	NULL
the	NULL
same	NULL
site	NULL
(	NULL
although	NULL
we	NULL
do	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
even	NULL
PKA	NULL
may	NULL
be	NULL
active	NULL
on	NULL
p65	NULL
in	NULL
vivo	NULL
)	NULL
.	NULL

These	NULL
results	NULL
,	NULL
which	NULL
showed	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
p65	NULL
is	NULL
phosphorylation-dependent	NULL
,	NULL
are	NULL
significant	NULL
because	NULL
until	NULL
now	NULL
only	NULL
phosphorylation	NULL
of	NULL
IB	NULL
molecules	NULL
was	NULL
known	NULL
as	NULL
a	NULL
potential	NULL
mechanism	NULL
of	NULL
NF-KB	NULL
activation	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
there	NULL
is	NULL
this	NULL
additional	NULL
level	NULL
of	NULL
control	NULL
which	NULL
directly	NULL
affects	NULL
the	NULL
DNA	NULL
interaction	NULL
of	NULL
the	NULL
transcriptionally	NULL
most	NULL
potent	NULL
activator	NULL
of	NULL
the	NULL
NF-xB/rel	NULL
family	NULL
(	NULL
Schmitz	NULL
and	NULL
Baeuerle	NULL
,	NULL
1991	NULL
)	NULL
.	NULL

p105	NULL
is	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
same	NULL
fashion	NULL
as	NULL
kBo	NULL
.	NULL

Because	NULL
both	NULL
NF-KB	NULL
precursors	NULL
are	NULL
phosphorylated	NULL
while	NULL
being	NULL
processed	NULL
,	NULL
and	NULL
since	NULL
the	NULL
modification	NULL
apparently	NULL
occurs	NULL
at	NULL
the	NULL
C-terminal	NULL
domains	NULL
which	NULL
mediate	NULL
the	NULL
interaction	NULL
of	NULL
both	NULL
p105	NULL
and	NULL
p100	NULL
with	NULL
p65	NULL
(	NULL
Naumann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
,	NULL
b	NULL
)	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
analyse	NULL
the	NULL
effect	NULL
of	NULL
modification	NULL
on	NULL
the	NULL
precursor-p65	NULL
interaction	NULL
in	NULL
vitro	NULL
.	NULL

Phosphorylation	NULL
of	NULL
a	NULL
site	NULL
in	NULL
the	NULL
repeat	NULL
domain	NULL
of	NULL
IxBa	NULL
by	NULL
PKA	NULL
abrogated	NULL
the	NULL
interaction	NULL
of	NULL
NF-KB	NULL
and	NULL
IxBa	NULL
(	NULL
D.Krappmann	NULL
and	NULL
C.Scheidereit	NULL
,	NULL
unpublished	NULL
data	NULL
)	NULL
and	NULL
phosphorylation	NULL
of	NULL
the	NULL
isolated	NULL
C-terminal	NULL
half	NULL
of	NULL
p105	NULL
inhibited	NULL
its	NULL
interaction	NULL
with	NULL
p50	NULL
(	NULL
Gerondakis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
interaction	NULL
of	NULL
the	NULL
entire	NULL
precursor	NULL
with	NULL
NF-KB/rel	NULL
factors	NULL
might	NULL
be	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
.	NULL

In	NULL
Figure	NULL
8B	NULL
we	NULL
show	NULL
with	NULL
recombinant	NULL
proteins	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
p105	NULL
to	NULL
interact	NULL
with	NULL
p65	NULL
is	NULL
abrogated	NULL
by	NULL
PKA	NULL
phosphorylation	NULL
:	NULL
p65	NULL
forms	NULL
complexes	NULL
with	NULL
p105	NULL
,	NULL
which	NULL
are	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
.	NULL

To	NULL
demonstrate	NULL
the	NULL
effect	NULL
of	NULL
phosphorylation	NULL
on	NULL
complex	NULL
formation	NULL
,	NULL
the	NULL
increase	NULL
of	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
after	NULL
kinase	NULL
treatment	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
which	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
the	NULL
PKA	NULL
inhibitor	NULL
H7	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
,	NULL
has	NULL
to	NULL
be	NULL
considered	NULL
.	NULL

Therefore	NULL
,	NULL
p65	NULL
was	NULL
treated	NULL
with	NULL
PKA	NULL
,	NULL
then	NULL
H7	NULL
was	NULL
added	NULL
and	NULL
incubated	NULL
with	NULL
unmodified	NULL
p105	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

This	NULL
led	NULL
to	NULL
p65	NULL
-p105	NULL
complex	NULL
formation	NULL
despite	NULL
the	NULL
phosphorylation	NULL
of	NULL
p65	NULL
.	NULL

When	NULL
p65	NULL
and	NULL
p105	NULL
were	NULL
instead	NULL
incubated	NULL
with	NULL
PKA	NULL
in	NULL
separate	NULL
reactions	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
H7	NULL
and	NULL
further	NULL
incubation	NULL
after	NULL
mixing	NULL
the	NULL
two	NULL
reactions	NULL
,	NULL
p65	NULL
-p105	NULL
complex	NULL
formation	NULL
no	NULL
longer	NULL
occurred	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
observed	NULL
p65	NULL
DNA	NULL
binding	NULL
activity	NULL
corresponded	NULL
to	NULL
that	NULL
of	NULL
phosphorylated	NULL
p65	NULL
alone	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
and	NULL
6	NULL
)	NULL
.	NULL

We	NULL
conclude	NULL
from	NULL
this	NULL
experiment	NULL
that	NULL
,	NULL
upon	NULL
phosphorylation	NULL
,	NULL
p105	NULL
loses	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
p65	NULL
,	NULL
whereas	NULL
phosphorylated	NULL
p65	NULL
can	NULL
still	NULL
interact	NULL
with	NULL
unmodified	NULL
p105	NULL
.	NULL

Thus	NULL
,	NULL
p105	NULL
is	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
as	NULL
is	NULL
IxBa	NULL
(	NULL
Ghosh	NULL
and	NULL
Baltimore	NULL
,	NULL
1990	NULL
)	NULL
.	NULL

Discussion	NULL
In	NULL
B	NULL
cells	NULL
,	NULL
some	NULL
nuclear	NULL
NF-KB	NULL
activity	NULL
is	NULL
constitutive	NULL
whereas	NULL
in	NULL
other	NULL
cells	NULL
nuclear	NULL
activity	NULL
is	NULL
obtained	NULL
only	NULL
after	NULL
cellular	NULL
stimulation	NULL
.	NULL

In	NULL
order	NULL
to	NULL
unravel	NULL
the	NULL
mechanisms	NULL
of	NULL
inducible	NULL
and	NULL
constitutive	NULL
NF-KB	NULL
activation	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
alterations	NULL
in	NULL
the	NULL
intracellular	NULL
localization	NULL
of	NULL
factors	NULL
.	NULL

We	NULL
have	NULL
followed	NULL
precursor	NULL
processing	NULL
and	NULL
IxBa	NULL
degradation	NULL
after	NULL
cytokine	NULL
stimulation	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

Secondly	NULL
,	NULL
we	NULL
have	NULL
analysed	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
these	NULL
proteins	NULL
following	NULL
stimulation	NULL
and	NULL
found	NULL
that	NULL
protein	NULL
phosphorylation	NULL
appears	NULL
to	NULL
trigger	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
in	NULL
intact	NULL
cells	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
rapid	NULL
induction	NULL
of	NULL
NF-xB	NULL
involved	NULL
activation	NULL
of	NULL
IxBa	NULL
complexes	NULL
as	NULL
well	NULL
as	NULL
of	NULL
NF-xB-precursor	NULL
complexes	NULL
as	NULL
it	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
concomitant	NULL
loss	NULL
of	NULL
IxBa	NULL
and	NULL
processing	NULL
of	NULL
p105	NULL
.	NULL

Processing	NULL
of	NULL
p100	NULL
was	NULL
induced	NULL
less	NULL
efficiently	NULL
.	NULL

The	NULL
very	NULL
fast	NULL
induction	NULL
of	NULL
precursor	NULL
processing	NULL
,	NULL
within	NULL
10	NULL
min	NULL
,	NULL
suggested	NULL
an	NULL
immediate	NULL
effect	NULL
of	NULL
TNF-a	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
slow	NULL
induction	NULL
of	NULL
p105-processing	NULL
observed	NULL
hours	NULL
after	NULL
induction	NULL
with	NULL
PMA	NULL
or	NULL
LPS	NULL
(	NULL
Cordle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Mercurio	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

All	NULL
factors	NULL
analysed	NULL
were	NULL
present	NULL
in	NULL
roughly	NULL
the	NULL
same	NULL
relative	NULL
amounts	NULL
in	NULL
HeLa	NULL
cells	NULL
and	NULL
Namalwa	NULL
cells	NULL
and	NULL
induction	NULL
led	NULL
to	NULL
a	NULL
nuclear	NULL
accumulation	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
,	NULL
and	NULL
of	NULL
minor	NULL
amounts	NULL
of	NULL
p52	NULL
but	NULL
not	NULL
of	NULL
c-rel	NULL
.	NULL

The	NULL
predominance	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
as	NULL
the	NULL
major	NULL
TNF-	NULL
@	NULL
-induced	NULL
factors	NULL
was	NULL
also	NULL
evident	NULL
when	NULL
analysing	NULL
the	NULL
induced	NULL
nuclear	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
c-rel	NULL
is	NULL
induced	NULL
with	NULL
a	NULL
longer	NULL
lag	NULL
period	NULL
than	NULL
p65	NULL
or	NULL
p50	NULL
,	NULL
as	NULL
has	NULL
been	NULL
demonstrated	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
Tan	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Doerre	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Our	NULL
co-precipitation	NULL
experiments	NULL
were	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
both	NULL
cell	NULL
types	NULL
contained	NULL
p65	NULL
in	NULL
complexes	NULL
either	NULL
with	NULL
p105	NULL
or	NULL
p100	NULL
,	NULL
or	NULL
as	NULL
heteromers	NULL
with	NULL
c-rel	NULL
or	NULL
p50	NULL
and	NULL
IxBa	NULL
,	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
studies	NULL
(	NULL
see	NULL
Introduction	NULL
)	NULL
.	NULL

From	NULL
the	NULL
results	NULL
of	NULL
earlier	NULL
work	NULL
(	NULL
Hatada	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Naumann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
)	NULL
we	NULL
also	NULL
expect	NULL
that	NULL
p65	NULL
,	NULL
like	NULL
other	NULL
NF-xB/rel	NULL
factors	NULL
,	NULL
forms	NULL
heterodimers	NULL
with	NULL
p10S	NULL
or	NULL
p100	NULL
,	NULL
and	NULL
that	NULL
p50-p65	NULL
heterodimers	NULL
form	NULL
heterotrimers	NULL
with	NULL
IxBa	NULL
.	NULL

It	NULL
thus	NULL
appears	NULL
that	NULL
TNF-a	NULL
specifically	NULL
affects	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
p65-p105	NULL
and	NULL
p65-p50-IxBa	NULL
complexes	NULL
by	NULL
inducing	NULL
processing	NULL
and	NULL
proteolysis	NULL
(	NULL
see	NULL
Figure	NULL
9	NULL
)	NULL
.	NULL

This	NULL
conclusion	NULL
4603	NULL
M.Naumann	NULL
and	NULL
C.Scheidereit	NULL
a	NULL
»	NULL
db	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

Phosphorylation	NULL
of	NULL
p65	NULL
affects	NULL
its	NULL
DNA	NULL
binding	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
HeLa	NULL
cells	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
TNF-a	NULL
(	NULL
lanes	NULL
2-5	NULL
)	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
,	NULL
prior	NULL
to	NULL
loading	NULL
on	NULL
the	NULL
gel	NULL
,	NULL
treated	NULL
with	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
(	NULL
SAP	NULL
.	NULL

,	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
heat-inactivated	NULL
SAP	NULL
(	NULL
dSAP	NULL
,	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
potato	NULL
acid	NULL
phosphatase	NULL
(	NULL
PAP	NULL
,	NULL
lane	NULL
5	NULL
)	NULL
and	NULL
assayed	NULL
by	NULL
EMSA	NULL
using	NULL
an	NULL
Ig	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
p6S5-containing	NULL
NF-KB	NULL
was	NULL
purified	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
TNF-a-induced	NULL
HeLa	NULL
cells	NULL
by	NULL
immuno-adsorption	NULL
to	NULL
an	NULL
anti-p65	NULL
antibody	NULL
column	NULL
and	NULL
elution	NULL
with	NULL
the	NULL
peptide	NULL
antigen	NULL
.	NULL

Eluted	NULL
immunopurified	NULL
NF-KB	NULL
was	NULL
assayed	NULL
by	NULL
EMSA	NULL
before	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
or	NULL
after	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
3	NULL
)	NULL
addition	NULL
of	NULL
SAP	NULL
or	NULL
dSAP	NULL
using	NULL
an	NULL
Igx	NULL
probe	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Recombinant	NULL
NF-KB	NULL
proteins	NULL
were	NULL
phosphorylated	NULL
with	NULL
PKA	NULL
and	NULL
[	NULL
y-	NULL
>	NULL
2P	NULL
]	NULL
ATP	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

The	NULL
phosphorylated	NULL
protein	NULL
species	NULL
are	NULL
indicated	NULL
with	NULL
arrows	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Recombinant	NULL
p50	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
p65	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
or	NULL
p50-p65	NULL
heterodimers	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
were	NULL
phosphorylated	NULL
in	NULL
vitro	NULL
with	NULL
PKA	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
and	NULL
6	NULL
)	NULL
or	NULL
incubated	NULL
with	NULL
control	NULL
buffer	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
3	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
tested	NULL
by	NULL
EMSA	NULL
,	NULL
using	NULL
the	NULL
Igx	NULL
enhancer	NULL
probe	NULL
.	NULL

Only	NULL
sections	NULL
of	NULL
the	NULL
autoradiograms	NULL
are	NULL
shown	NULL
.	NULL

was	NULL
also	NULL
strongly	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
,	NULL
at	NULL
the	NULL
time	NULL
of	NULL
TNF-	NULL
@	NULL
-induced	NULL
precursor	NULL
processing	NULL
and	NULL
IxBa	NULL
degradation	NULL
,	NULL
these	NULL
molecules	NULL
became	NULL
heavily	NULL
phosphorylated	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

Unexpectedly	NULL
,	NULL
p65	NULL
was	NULL
also	NULL
phosphorylated	NULL
at	NULL
the	NULL
same	NULL
time	NULL
point	NULL
,	NULL
whereas	NULL
neither	NULL
c-rel	NULL
,	NULL
nor	NULL
p50	NULL
nor	NULL
p52	NULL
was	NULL
modified	NULL
.	NULL

At	NULL
present	NULL
,	NULL
we	NULL
can	NULL
not	NULL
determine	NULL
whether	NULL
phosphorylation	NULL
of	NULL
p65	NULL
is	NULL
another	NULL
prerequisite	NULL
for	NULL
processing	NULL
and/or	NULL
IxBa	NULL
degradation	NULL
,	NULL
or	NULL
a	NULL
parallel	NULL
phenomenon	NULL
,	NULL
by	NULL
which	NULL
the	NULL
later	NULL
nuclear	NULL
activity	NULL
of	NULL
this	NULL
factor	NULL
is	NULL
enhanced	NULL
(	NULL
see	NULL
below	NULL
)	NULL
.	NULL

The	NULL
intracellular	NULL
distribution	NULL
of	NULL
c-rel	NULL
did	NULL
not	NULL
change	NULL
4604	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

The	NULL
p65S-p105	NULL
association	NULL
is	NULL
affected	NULL
by	NULL
phosphorylation	NULL
with	NULL
protein	NULL
kinase	NULL
A	NULL
in	NULL
vitro	NULL
.	NULL

Band	NULL
shift	NULL
analysis	NULL
of	NULL
the	NULL
influence	NULL
of	NULL
phosphorylation	NULL
on	NULL
p105-p65	NULL
complex	NULL
formation	NULL
,	NULL
using	NULL
the	NULL
H2-K	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
(	NULL
lanes	NULL
1-6	NULL
)	NULL
.	NULL

As	NULL
indicated	NULL
,	NULL
recombinant	NULL
p65	NULL
was	NULL
assayed	NULL
without	NULL
modification	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
after	NULL
phosphorylation	NULL
with	NULL
PKA	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
,	NULL
after	NULL
treatment	NULL
with	NULL
PKA	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
PKA	NULL
inhibitor	NULL
H7	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
or	NULL
after	NULL
complex	NULL
formation	NULL
with	NULL
p105	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
.	NULL

p65	NULL
was	NULL
phosphorylated	NULL
with	NULL
PKA	NULL
,	NULL
H7	NULL
was	NULL
added	NULL
and	NULL
p65	NULL
was	NULL
further	NULL
incubated	NULL
with	NULL
p105	NULL
before	NULL
adding	NULL
the	NULL
DNA	NULL
probe	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
.	NULL

In	NULL
separate	NULL
reactions	NULL
,	NULL
both	NULL
p65	NULL
and	NULL
p105	NULL
were	NULL
phosphorylated	NULL
with	NULL
PKA	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
addition	NULL
of	NULL
H7	NULL
;	NULL
then	NULL
the	NULL
reactions	NULL
were	NULL
mixed	NULL
and	NULL
incubated	NULL
together	NULL
before	NULL
adding	NULL
the	NULL
DNA	NULL
probe	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
only	NULL
the	NULL
protein-DNA	NULL
complex	NULL
is	NULL
shown	NULL
and	NULL
that	NULL
p65-p105	NULL
complex	NULL
formation	NULL
is	NULL
reflected	NULL
by	NULL
the	NULL
absence	NULL
of	NULL
p65S-	NULL
DNA	NULL
complexes	NULL
.	NULL

Cellular	NULL
stimulation	NULL
z	NULL
~	NULL
//	NULL
\	NULL
kinase	NULL
(	NULL
s	NULL
)	NULL
/	NULL
protease	NULL
(	NULL
s	NULL
)	NULL
precursor	NULL
\	NULL
’	NULL
C-lerminu	NULL
:	NULL
\	NULL
p105-p66	NULL
p50-p65-IxBa	NULL
p50-p65	NULL
P	NULL
/	NULL
pidg-pes	NULL
IxBa	NULL
:	NULL
degradation	NULL
cytoplasmic	NULL
nuclear	NULL
translocation	NULL
pool	NULL
gene	NULL
activation	NULL
Fig	NULL
.	NULL

9	NULL
.	NULL

Model	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
.	NULL

Signal-induced	NULL
kinases	NULL
phosphorylate	NULL
IxBa	NULL
,	NULL
the	NULL
C-terminal	NULL
halves	NULL
of	NULL
the	NULL
precursors	NULL
and	NULL
p65	NULL
.	NULL

After	NULL
degradation	NULL
of	NULL
phosphorylated	NULL
IxBa	NULL
and	NULL
processing	NULL
of	NULL
the	NULL
precursors	NULL
,	NULL
active	NULL
phosphorylated	NULL
p50-p65	NULL
is	NULL
released	NULL
.	NULL

despite	NULL
the	NULL
complete	NULL
disappearance	NULL
of	NULL
xB	NULL
after	NULL
stimulation	NULL
.	NULL

An	NULL
interesting	NULL
possibility	NULL
is	NULL
that	NULL
the	NULL
identity	NULL
of	NULL
the	NULL
rel/NF-xB	NULL
components	NULL
,	NULL
and	NULL
not	NULL
only	NULL
that	NULL
of	NULL
the	NULL
IxB	NULL
moieties	NULL
,	NULL
could	NULL
determine	NULL
which	NULL
complexes	NULL
can	NULL
be	NULL
activated	NULL
through	NULL
contributing	NULL
to	NULL
the	NULL
recognition	NULL
by	NULL
modifying	NULL
enzymes	NULL
.	NULL

In	NULL
any	NULL
case	NULL
,	NULL
inducible	NULL
phosphorylation	NULL
of	NULL
the	NULL
precursors	NULL
and	NULL
of	NULL
IxBa	NULL
strongly	NULL
suggests	NULL
that	NULL
stimulus-dependent	NULL
kinases	NULL
act	NULL
on	NULL
these	NULL
structures	NULL
to	NULL
induce	NULL
the	NULL
action	NULL
of	NULL
proteases	NULL
.	NULL

Activation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
by	NULL
numerous	NULL
inducers	NULL
,	NULL
including	NULL
TNF-a	NULL
,	NULL
can	NULL
be	NULL
blocked	NULL
with	NULL
oxygen-radical	NULL
scavenger	NULL
compounds	NULL
(	NULL
Staal	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
,	NULL
which	NULL
led	NULL
to	NULL
the	NULL
proposal	NULL
that	NULL
ROIs	NULL
are	NULL
crucial	NULL
second	NULL
messengers	NULL
.	NULL

This	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
observation	NULL
that	NULL
the	NULL
oxygen-radical	NULL
forming	NULL
compound	NULL
hydrogen	NULL
peroxide	NULL
also	NULL
induces	NULL
NF-KB	NULL
(	NULL
Schreck	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
)	NULL
.	NULL

Our	NULL
demonstration	NULL
that	NULL
rapid	NULL
incorporation	NULL
of	NULL
phosphoryl	NULL
groups	NULL
into	NULL
NF-	NULL
«	NULL
B-IxB	NULL
complexes	NULL
is	NULL
the	NULL
final	NULL
modification	NULL
imposed	NULL
by	NULL
TNF-	NULL
stimulation	NULL
on	NULL
NF-	NULL
«	NULL
xB-IxB	NULL
suggests	NULL
that	NULL
ROIs	NULL
might	NULL
instead	NULL
act	NULL
upstream	NULL
of	NULL
a	NULL
kinase	NULL
or	NULL
protease	NULL
.	NULL

Induction	NULL
of	NULL
NF-KB	NULL
by	NULL
hydrogen	NULL
peroxide	NULL
in	NULL
fact	NULL
led	NULL
to	NULL
phosphorylation	NULL
of	NULL
the	NULL
same	NULL
subunits	NULL
which	NULL
were	NULL
modified	NULL
after	NULL
stimulation	NULL
with	NULL
TNF-a	NULL
.	NULL

Nuclear	NULL
translocation	NULL
of	NULL
NF-xB	NULL
after	NULL
phorbol	NULL
ester	NULL
(	NULL
PMA	NULL
)	NULL
stimulation	NULL
also	NULL
co	NULL
incided	NULL
with	NULL
protein	NULL
phosphorylation	NULL
of	NULL
cytoplasmic	NULL
complexes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
for	NULL
each	NULL
stimulating	NULL
agent	NULL
the	NULL
(	NULL
different	NULL
)	NULL
time	NULL
points	NULL
of	NULL
nuclear	NULL
translocation	NULL
coincided	NULL
with	NULL
the	NULL
time	NULL
points	NULL
of	NULL
maximal	NULL
phosphate	NULL
incorporation	NULL
,	NULL
which	NULL
strongly	NULL
supports	NULL
the	NULL
notion	NULL
that	NULL
phosphorylation	NULL
is	NULL
the	NULL
modifying	NULL
signal	NULL
which	NULL
triggers	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
proteolysis	NULL
.	NULL

A	NULL
striking	NULL
difference	NULL
between	NULL
HeLa	NULL
cells	NULL
and	NULL
B	NULL
cells	NULL
was	NULL
noted	NULL
when	NULL
comparing	NULL
the	NULL
phosphorylation	NULL
state	NULL
of	NULL
the	NULL
NF-xB/IxB	NULL
proteins	NULL
.	NULL

Whereas	NULL
in	NULL
HeLa	NULL
cells	NULL
phosphorylation	NULL
of	NULL
p65	NULL
was	NULL
strictly	NULL
dependent	NULL
on	NULL
stimulation	NULL
with	NULL
an	NULL
inducing	NULL
agent	NULL
,	NULL
in	NULL
Namalwa	NULL
cells	NULL
it	NULL
appeared	NULL
to	NULL
be	NULL
constitutive	NULL
,	NULL
with	NULL
only	NULL
a	NULL
weak	NULL
increase	NULL
after	NULL
cytokine	NULL
addition	NULL
.	NULL

Furthermore	NULL
,	NULL
IxBa	NULL
appeared	NULL
in	NULL
B	NULL
cells	NULL
as	NULL
two	NULL
constitutively	NULL
and	NULL
strongly	NULL
phosphorylated	NULL
species	NULL
,	NULL
one	NULL
of	NULL
which	NULL
persisted	NULL
after	NULL
initial	NULL
increase	NULL
and	NULL
one	NULL
of	NULL
which	NULL
disappeared	NULL
rapidly	NULL
after	NULL
stimulation	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
B	NULL
lymphocytes	NULL
revealed	NULL
a	NULL
stronger	NULL
constitutive	NULL
phosphorylation	NULL
of	NULL
both	NULL
precursors	NULL
than	NULL
observed	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

Obviously	NULL
,	NULL
in	NULL
B	NULL
cells	NULL
kinases	NULL
are	NULL
constitutively	NULL
active	NULL
,	NULL
which	NULL
may	NULL
explain	NULL
the	NULL
constitutive	NULL
NF-KB	NULL
activity	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

The	NULL
constant	NULL
phosphorylation	NULL
of	NULL
IxBa	NULL
is	NULL
in	NULL
agreement	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
IKBa	NULL
is	NULL
more	NULL
unstable	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
with	NULL
a	NULL
half-life	NULL
of	NULL
~0.5	NULL
h	NULL
,	NULL
as	NULL
compared	NULL
with	NULL
1	NULL
h	NULL
in	NULL
Jurkat	NULL
or	NULL
HeLa	NULL
cells	NULL
(	NULL
Rice	NULL
and	NULL
Ernst	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
continuous	NULL
de	NULL
novo	NULL
synthesis	NULL
of	NULL
IxBa	NULL
is	NULL
apparently	NULL
accompanied	NULL
by	NULL
ongoing	NULL
phosphorylation	NULL
needed	NULL
to	NULL
maintain	NULL
the	NULL
high	NULL
turnover	NULL
.	NULL

Collectively	NULL
,	NULL
these	NULL
observations	NULL
strongly	NULL
support	NULL
the	NULL
model	NULL
that	NULL
kinases	NULL
which	NULL
are	NULL
cell-specifically	NULL
active	NULL
or	NULL
which	NULL
are	NULL
inducible	NULL
,	NULL
trigger	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
by	NULL
directly	NULL
phosphorylating	NULL
the	NULL
precursors	NULL
,	NULL
IKBa	NULL
and	NULL
even	NULL
p65	NULL
.	NULL

Several	NULL
in	NULL
vitro	NULL
studies	NULL
showed	NULL
that	NULL
phosphorylation	NULL
of	NULL
IB	NULL
abolishes	NULL
its	NULL
interaction	NULL
with	NULL
NF-KB	NULL
(	NULL
see	NULL
Introduction	NULL
)	NULL
.	NULL

We	NULL
showed	NULL
here	NULL
that	NULL
PKA	NULL
phosphorylates	NULL
p105	NULL
in	NULL
vitro	NULL
at	NULL
its	NULL
C-terminal	NULL
domain	NULL
and	NULL
that	NULL
,	NULL
as	NULL
observed	NULL
for	NULL
IxBa	NULL
,	NULL
upon	NULL
phosphorylation	NULL
in	NULL
vitro	NULL
,	NULL
p105	NULL
lost	NULL
its	NULL
ability	NULL
to	NULL
interact	NULL
with	NULL
p65	NULL
.	NULL

Similarly	NULL
,	NULL
IxBy	NULL
showed	NULL
impaired	NULL
interaction	NULL
with	NULL
either	NULL
p50	NULL
or	NULL
c-rel	NULL
homodimers	NULL
after	NULL
modification	NULL
with	NULL
PKA	NULL
(	NULL
Gerondakis	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

Phosphorylation	NULL
of	NULL
IxBa	NULL
at	NULL
a	NULL
single	NULL
site	NULL
in	NULL
the	NULL
ankyrin-like	NULL
repeat	NULL
domain	NULL
likewise	NULL
led	NULL
to	NULL
a	NULL
dissociation	NULL
of	NULL
recombinant	NULL
IxBa-NF-	NULL
«	NULL
xB	NULL
complexes	NULL
in	NULL
vitro	NULL
(	NULL
unpublished	NULL
data	NULL
)	NULL
.	NULL

The	NULL
site	NULL
which	NULL
is	NULL
phosphorylated	NULL
in	NULL
IxBa	NULL
by	NULL
both	NULL
PKA	NULL
and	NULL
PKC	NULL
is	NULL
also	NULL
conserved	NULL
in	NULL
p105	NULL
(	NULL
unpublished	NULL
observation	NULL
)	NULL
,	NULL
making	NULL
it	NULL
probable	NULL
that	NULL
it	NULL
is	NULL
also	NULL
utilized	NULL
by	NULL
the	NULL
kinases	NULL
in	NULL
p105	NULL
.	NULL

The	NULL
effects	NULL
are	NULL
thus	NULL
highly	NULL
specific	NULL
and	NULL
not	NULL
due	NULL
to	NULL
a	NULL
mere	NULL
hyper-phosphorylation	NULL
;	NULL
this	NULL
is	NULL
also	NULL
supported	NULL
by	NULL
our	NULL
observation	NULL
that	NULL
phosphorylation	NULL
of	NULL
p65	NULL
did	NULL
not	NULL
abolish	NULL
its	NULL
interaction	NULL
with	NULL
p105	NULL
,	NULL
while	NULL
phosphorylation	NULL
of	NULL
p105	NULL
interfered	NULL
with	NULL
its	NULL
interaction	NULL
with	NULL
p65	NULL
(	NULL
see	NULL
Figure	NULL
8	NULL
)	NULL
.	NULL

The	NULL
biochemical	NULL
experiments	NULL
thus	NULL
suggest	NULL
that	NULL
phosphorylation	NULL
of	NULL
complexes	NULL
containing	NULL
IxBa	NULL
or	NULL
p105	NULL
leads	NULL
to	NULL
their	NULL
spontaneous	NULL
dissociation	NULL
.	NULL

In	NULL
apparent	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
that	NULL
in	NULL
intact	NULL
cells	NULL
phosphorylated	NULL
precursor	NULL
molecules	NULL
or	NULL
phosphorylated	NULL
IxBa	NULL
were	NULL
still	NULL
co-precipitated	NULL
with	NULL
p65	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
observations	NULL
made	NULL
for	NULL
IxBa	NULL
by	NULL
Beg	NULL
er	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
and	NULL
Brown	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
.	NULL

This	NULL
might	NULL
indicate	NULL
that	NULL
phosphorylation	NULL
does	NULL
not	NULL
abrogate	NULL
protein-protein	NULL
interactions	NULL
prior	NULL
to	NULL
the	NULL
action	NULL
of	NULL
proteases	NULL
.	NULL

In	NULL
this	NULL
context	NULL
it	NULL
must	NULL
be	NULL
taken	NULL
into	NULL
account	NULL
that	NULL
at	NULL
the	NULL
time	NULL
of	NULL
TNF-o-dependent	NULL
hyperphosphorylation	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
IKB	NULL
&	NULL
and	NULL
precursor	NULL
Mechanism	NULL
of	NULL
NF-xB	NULL
activation	NULL
proteins	NULL
were	NULL
already	NULL
strongly	NULL
diminished	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
,	NULL
therefore	NULL
,	NULL
that	NULL
only	NULL
a	NULL
small	NULL
fraction	NULL
of	NULL
the	NULL
originally	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
still	NULL
associated	NULL
and	NULL
that	NULL
the	NULL
vast	NULL
majority	NULL
was	NULL
dissociated	NULL
and	NULL
degraded	NULL
or	NULL
processed	NULL
.	NULL

The	NULL
off-rate	NULL
for	NULL
the	NULL
dissociation	NULL
could	NULL
be	NULL
slow	NULL
enough	NULL
to	NULL
co-precipitate	NULL
some	NULL
fraction	NULL
of	NULL
the	NULL
phosphorylated	NULL
proteins	NULL
.	NULL

Alternatively	NULL
,	NULL
phosphorylation	NULL
of	NULL
the	NULL
complexes	NULL
could	NULL
strongly	NULL
enhance	NULL
recognition	NULL
by	NULL
proteases	NULL
and	NULL
degradation	NULL
or	NULL
processing	NULL
of	NULL
IxBa	NULL
or	NULL
p105/p100	NULL
could	NULL
occur	NULL
within	NULL
their	NULL
protein	NULL
complexes	NULL
,	NULL
without	NULL
dissociation	NULL
of	NULL
the	NULL
inhibitory	NULL
domains	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
propose	NULL
that	NULL
phosphorylation	NULL
activates	NULL
NF-KB	NULL
by	NULL
inducing	NULL
the	NULL
action	NULL
of	NULL
proteases	NULL
,	NULL
which	NULL
recognize	NULL
their	NULL
phosphorylated	NULL
substrates	NULL
either	NULL
in	NULL
the	NULL
complexes	NULL
or	NULL
after	NULL
dissociation	NULL
.	NULL

Future	NULL
experiments	NULL
will	NULL
address	NULL
the	NULL
exact	NULL
mechanism	NULL
of	NULL
phos-phorylation-induced	NULL
proteolysis	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
map	NULL
the	NULL
sites	NULL
which	NULL
are	NULL
modified	NULL
in	NULL
vivo	NULL
and	NULL
to	NULL
identify	NULL
the	NULL
kinases	NULL
and	NULL
proteases	NULL
.	NULL

Our	NULL
precipitation	NULL
experiments	NULL
with	NULL
anti-p65	NULL
antibodies	NULL
revealed	NULL
further	NULL
molecules	NULL
in	NULL
the	NULL
size	NULL
range	NULL
of	NULL
the	NULL
precursors	NULL
,	NULL
which	NULL
were	NULL
phosphorylated	NULL
constitutively	NULL
and	NULL
which	NULL
interacted	NULL
with	NULL
p65	NULL
,	NULL
but	NULL
apparently	NULL
not	NULL
with	NULL
the	NULL
precursors	NULL
.	NULL

These	NULL
might	NULL
be	NULL
specific	NULL
kinases	NULL
or	NULL
proteases	NULL
or	NULL
other	NULL
functionally	NULL
important	NULL
components	NULL
.	NULL

We	NULL
are	NULL
currently	NULL
attempting	NULL
to	NULL
isolate	NULL
these	NULL
proteins	NULL
.	NULL

A	NULL
surprising	NULL
finding	NULL
of	NULL
our	NULL
study	NULL
was	NULL
that	NULL
the	NULL
phosphorylation	NULL
of	NULL
p65	NULL
was	NULL
constitutive	NULL
in	NULL
Namalwa	NULL
cells	NULL
but	NULL
inducible	NULL
in	NULL
HeLa	NULL
cells	NULL
.	NULL

We	NULL
showed	NULL
that	NULL
cellular	NULL
nuclear	NULL
NF-	NULL
«	NULL
xB	NULL
containing	NULL
p65	NULL
is	NULL
phosphorylated	NULL
and	NULL
that	NULL
dephosphorylation	NULL
leads	NULL
to	NULL
a	NULL
marked	NULL
decrease	NULL
in	NULL
its	NULL
DNA	NULL
binding	NULL
affinity	NULL
.	NULL

These	NULL
experiments	NULL
uncover	NULL
a	NULL
novel	NULL
mechanism	NULL
of	NULL
NF-KB	NULL
activation	NULL
by	NULL
kinases	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
nuclear	NULL
translocation	NULL
,	NULL
kinases	NULL
directly	NULL
affect	NULL
the	NULL
nuclear	NULL
activity	NULL
of	NULL
NF-KB	NULL
by	NULL
enhancing	NULL
the	NULL
affinity	NULL
towards	NULL
the	NULL
target	NULL
genes	NULL
.	NULL

This	NULL
level	NULL
of	NULL
control	NULL
has	NULL
also	NULL
been	NULL
described	NULL
for	NULL
other	NULL
transcription	NULL
factors	NULL
(	NULL
for	NULL
reviews	NULL
see	NULL
Hunter	NULL
and	NULL
Karin	NULL
,	NULL
1992	NULL
;	NULL
Nichols	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
the	NULL
sites	NULL
modified	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
will	NULL
have	NULL
to	NULL
be	NULL
performed	NULL
in	NULL
order	NULL
to	NULL
understand	NULL
how	NULL
p65	NULL
is	NULL
regulated	NULL
by	NULL
phosphorylation	NULL
,	NULL
whether	NULL
it	NULL
is	NULL
by	NULL
enhancing	NULL
the	NULL
activation	NULL
of	NULL
cytoplasmic	NULL
complexes	NULL
,	NULL
improving	NULL
nuclear	NULL
uptake	NULL
,	NULL
increasing	NULL
the	NULL
dimerization	NULL
efficiency	NULL
or	NULL
directly	NULL
elevating	NULL
the	NULL
DNA	NULL
binding	NULL
affinity	NULL
.	NULL

Our	NULL
data	NULL
provide	NULL
evidence	NULL
for	NULL
the	NULL
last	NULL
possibility	NULL
,	NULL
but	NULL
we	NULL
can	NULL
not	NULL
exclude	NULL
the	NULL
possibility	NULL
that	NULL
p65	NULL
phosphorylation	NULL
has	NULL
effects	NULL
at	NULL
different	NULL
levels	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Cell	NULL
culture	NULL
Namalwa	NULL
and	NULL
70Z/3	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
BRL/Gibeo	NULL
)	NULL
,	NULL
and	NULL
HeLa	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
minimum	NULL
essential	NULL
medium	NULL
(	NULL
S-MEM	NULL
)	NULL
.	NULL

The	NULL
media	NULL
were	NULL
supplemented	NULL
with	NULL
4	NULL
mM	NULL
glutamine	NULL
,	NULL
1	NULL
%	NULL
non-essential	NULL
amino	NULL
acids	NULL
,	NULL
100	NULL
U/mi	NULL
penicillin	NULL
,	NULL
100	NULL
ug/ml	NULL
!	NULL

streptomycin	NULL
and	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
for	NULL
HeLa	NULL
cells	NULL
5	NULL
%	NULL
newborn	NULL
calf	NULL
serum	NULL
(	NULL
NCS	NULL
)	NULL
was	NULL
used	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
10	NULL
ng/ml	NULL
TNF-a	NULL
(	NULL
Gibeo/BRL	NULL
)	NULL
or	NULL
250	NULL
uM	NULL
H	NULL
;	NULL
O	NULL
;	NULL
(	NULL
Merck	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Recombinant	NULL
proteins	NULL
Expression	NULL
plasmids	NULL
pETpS50	NULL
(	NULL
amino	NULL
acids	NULL
1-368	NULL
)	NULL
,	NULL
pETp105	NULL
(	NULL
amino	NULL
acids	NULL
18-970	NULL
)	NULL
,	NULL
pS2pAR	NULL
(	NULL
ARI	NULL
)	NULL
(	NULL
amino	NULL
acids	NULL
1-373	NULL
)	NULL
,	NULL
pRSETCp100	NULL
(	NULL
amino	NULL
acids	NULL
1-900	NULL
)	NULL
and	NULL
pETp6S5	NULL
(	NULL
amino	NULL
acids	NULL
1-550	NULL
)	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
Naumann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993a	NULL
,	NULL
b	NULL
)	NULL
.	NULL

The	NULL
constructs	NULL
were	NULL
used	NULL
for	NULL
transformation	NULL
of	NULL
BL21	NULL
[	NULL
DE3	NULL
]	NULL
pLysS	NULL
cells	NULL
and	NULL
bacterial	NULL
proteins	NULL
were	NULL
gel	NULL
purified	NULL
and	NULL
renatured	NULL
as	NULL
described	NULL
(	NULL
Hatada	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

4605	NULL
M.Naumann	NULL
and	NULL
C.Scheidereit	NULL
Immunoblots	NULL
Cytoplasmic	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
using	NULL
a	NULL
non-ionic	NULL
detergent	NULL
method	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
and	NULL
resuspended	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
and	NULL
0.15	NULL
%	NULL
NP-40	NULL
was	NULL
added	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
left	NULL
for	NULL
10	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
subsequently	NULL
centrifuged	NULL
at	NULL
1000	NULL
g	NULL
for	NULL
10	NULL
min	NULL
.	NULL

The	NULL
supernatant	NULL
was	NULL
used	NULL
as	NULL
cytoplasmic	NULL
extract	NULL
and	NULL
the	NULL
pellet	NULL
was	NULL
treated	NULL
with	NULL
buffer	NULL
C	NULL
(	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1983	NULL
)	NULL
for	NULL
10	NULL
min	NULL
to	NULL
yield	NULL
the	NULL
nuclear	NULL
extract	NULL
.	NULL

The	NULL
disruption	NULL
of	NULL
the	NULL
cytosolic	NULL
membrane	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
efficient	NULL
than	NULL
in	NULL
the	NULL
Dignam	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
protocol	NULL
,	NULL
without	NULL
affecting	NULL
the	NULL
nuclear	NULL
envelope	NULL
.	NULL

The	NULL
cellular	NULL
extracts	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
blotted	NULL
onto	NULL
PVDF	NULL
Immobilon	NULL
membranes	NULL
(	NULL
Millipore	NULL
)	NULL
in	NULL
blotting	NULL
buffer	NULL
(	NULL
25	NULL
mM	NULL
Tris-HCl	NULL
pH	NULL
8.3	NULL
,	NULL
0.01	NULL
%	NULL
SDS	NULL
,	NULL
0.1	NULL
mM	NULL
dithioerithritol	NULL
,	NULL
20	NULL
%	NULL
methanol	NULL
)	NULL
as	NULL
described	NULL
recently	NULL
(	NULL
Naumann	NULL
et	NULL
a/	NULL
.	NULL

,	NULL
1993a	NULL
)	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
Gel	NULL
retardation	NULL
assays	NULL
were	NULL
performed	NULL
with	NULL
either	NULL
an	NULL
H-2K	NULL
or	NULL
an	NULL
IgK	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

The	NULL
DNA	NULL
binding	NULL
reactions	NULL
were	NULL
performed	NULL
with	NULL
the	NULL
indicated	NULL
fraction	NULL
or	NULL
recombinant	NULL
protein	NULL
in	NULL
20	NULL
pl	NULL
binding	NULL
buffer	NULL
[	NULL
2	NULL
ug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
1	NULL
ug	NULL
BSA	NULL
,	NULL
5	NULL
mM	NULL
DTT	NULL
,	NULL
20	NULL
mM	NULL
HEPES	NULL
(	NULL
pH	NULL
8.4	NULL
)	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
and	NULL
8	NULL
%	NULL
Ficoll	NULL
]	NULL
for	NULL
20	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
HeLa	NULL
cell	NULL
nuclear	NULL
extract	NULL
fraction	NULL
was	NULL
dephosphorylated	NULL
with	NULL
0.05	NULL
U	NULL
acid	NULL
phosphatase	NULL
(	NULL
Sigma	NULL
)	NULL
or	NULL
2.5	NULL
U	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
for	NULL
30	NULL
min	NULL
at	NULL
37°C	NULL
in	NULL
the	NULL
above	NULL
reaction	NULL
buffer	NULL
prior	NULL
to	NULL
the	NULL
DNA	NULL
binding	NULL
reaction	NULL
.	NULL

As	NULL
a	NULL
control	NULL
heat	NULL
denatured	NULL
shrimp	NULL
alkaline	NULL
phosphatase	NULL
was	NULL
used	NULL
,	NULL
Purified	NULL
NF-KB	NULL
was	NULL
obtained	NULL
from	NULL
nuclear	NULL
extracts	NULL
of	NULL
TNF-o-stimulated	NULL
HeLa	NULL
cells	NULL
.	NULL

Affinity	NULL
purification	NULL
was	NULL
performed	NULL
with	NULL
an	NULL
anti-p65	NULL
antibody	NULL
column	NULL
from	NULL
which	NULL
NF-xB	NULL
was	NULL
eluted	NULL
by	NULL
competition	NULL
with	NULL
the	NULL
epitope-containing	NULL
peptide	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
run	NULL
in	NULL
12.5	NULL
mM	NULL
Tris	NULL
and	NULL
96	NULL
mM	NULL
glycine	NULL
pH	NULL
8.3	NULL
.	NULL

In	NULL
vitro	NULL
phosphorylation	NULL
In	NULL
vitro	NULL
phosphorylation	NULL
of	NULL
recombinant	NULL
proteins	NULL
(	NULL
50	NULL
ng	NULL
each	NULL
)	NULL
was	NULL
carried	NULL
out	NULL
with	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKA	NULL
)	NULL
(	NULL
Promega	NULL
)	NULL
in	NULL
PKA	NULL
buffer	NULL
(	NULL
40	NULL
mM	NULL
Tris-HCl	NULL
pH	NULL
7.4	NULL
,	NULL
20	NULL
mM	NULL
MgOAc	NULL
,	NULL
0.2	NULL
mM	NULL
ATP	NULL
,	NULL
with	NULL
or	NULL
without	NULL
40	NULL
uCi	NULL
for	NULL
15	NULL
min	NULL
at	NULL
30°C	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
visualized	NULL
by	NULL
autoradiography	NULL
.	NULL

For	NULL
testing	NULL
PKA-dependent	NULL
interactions	NULL
of	NULL
p6S	NULL
and	NULL
p105	NULL
by	NULL
EMSA	NULL
,	NULL
the	NULL
PKA	NULL
inhibitor	NULL
H7	NULL
[	NULL
1-	NULL
(	NULL
5-isoquinolinesulfonyl	NULL
)	NULL
-2-methylpiperazine	NULL
dihydro-chloride	NULL
]	NULL
(	NULL
Calbiochem	NULL
)	NULL
was	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
3	NULL
mM	NULL
.	NULL

The	NULL
indicated	NULL
components	NULL
or	NULL
the	NULL
appropriate	NULL
buffers	NULL
were	NULL
subsequently	NULL
added	NULL
,	NULL
followed	NULL
by	NULL
the	NULL
probe	NULL
in	NULL
DNA	NULL
binding	NULL
buffer	NULL
.	NULL

The	NULL
total	NULL
incubation	NULL
time	NULL
was	NULL
1	NULL
h	NULL
,	NULL
with	NULL
15	NULL
min	NULL
for	NULL
each	NULL
step	NULL
at	NULL
30°C	NULL
,	NULL
before	NULL
loading	NULL
to	NULL
the	NULL
EMSA	NULL
gel	NULL
.	NULL

Antisera	NULL
The	NULL
anti-p105C	NULL
and	NULL
the	NULL
anti-pl00N	NULL
antisera	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
Hatada	NULL
ert	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Naumann	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993b	NULL
)	NULL
.	NULL

The	NULL
anti-IxBo	NULL
antibody	NULL
was	NULL
raised	NULL
against	NULL
recombinant	NULL
,	NULL
gel-purified	NULL
(	NULL
amino	NULL
acids	NULL
51-317	NULL
)	NULL
.	NULL

The	NULL
anti-p100C	NULL
antiserum	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
C-terminal	NULL
part	NULL
of	NULL
the	NULL
p100	NULL
molecule	NULL
comprising	NULL
amino	NULL
acids	NULL
445-9200	NULL
.	NULL

The	NULL
anti-p105N	NULL
antibody	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
comprising	NULL
amino	NULL
acids	NULL
273-290	NULL
.	NULL

Anti-p65	NULL
antibody	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
comprising	NULL
amino	NULL
acids	NULL
6-20	NULL
of	NULL
human	NULL
p65	NULL
.	NULL

The	NULL
anti-c-rel	NULL
antiserum	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
comprising	NULL
residues	NULL
572-586	NULL
of	NULL
human	NULL
c-rel	NULL
.	NULL

In	NULL
vivo	NULL
labelling	NULL
of	NULL
cells	NULL
and	NULL
immunoprecipitation	NULL
Hela	NULL
or	NULL
Namalwa	NULL
cells	NULL
(	NULL
~10	NULL
'	NULL
cells/ml	NULL
)	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
methionine-free	NULL
EMEM	NULL
(	NULL
ICN	NULL
)	NULL
and	NULL
incubated	NULL
for	NULL
4	NULL
h	NULL
with	NULL
300	NULL
pCi/ml	NULL
[	NULL
*°S	NULL
]	NULL
methionine	NULL
in	NULL
methionine-free	NULL
EMEM	NULL
containing	NULL
2	NULL
%	NULL
glutamine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
dialysed	NULL
serum	NULL
.	NULL

Prior	NULL
to	NULL
induction	NULL
with	NULL
TNF-a	NULL
the	NULL
cells	NULL
were	NULL
chased	NULL
with	NULL
cold	NULL
methionine	NULL
(	NULL
2	NULL
mM	NULL
)	NULL
.	NULL

After	NULL
induction	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
in	NULL
PBS	NULL
and	NULL
lysed	NULL
in	NULL
ice-cold	NULL
RIPA	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
1	NULL
%	NULL
deoxycholate	NULL
,	NULL
1	NULL
%	NULL
NP-40	NULL
,	NULL
0.15	NULL
%	NULL
SDS	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mM	NULL
EGTA	NULL
,	NULL
10	NULL
mM	NULL
NaF	NULL
,	NULL
10	NULL
mM	NULL
K	NULL
,	NULL
HPO	NULL
,	NULL
,	NULL
100	NULL
uM	NULL
PMSE	NULL
,	NULL
1	NULL
%	NULL
Trasylol	NULL
and	NULL
10	NULL
uM	NULL
pepstatin	NULL
A	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
disrupted	NULL
by	NULL
passing	NULL
the	NULL
lysate	NULL
several	NULL
times	NULL
through	NULL
a	NULL
21	NULL
gauge	NULL
syringe	NULL
.	NULL

The	NULL
cell	NULL
debris	NULL
was	NULL
centrifuged	NULL
and	NULL
the	NULL
supernatant	NULL
subsequently	NULL
incubated	NULL
with	NULL
antisera	NULL
coupled	NULL
to	NULL
protein	NULL
A	NULL
beads	NULL
.	NULL

The	NULL
preimmune	NULL
sera	NULL
or	NULL
antisera	NULL
,	NULL
5	NULL
ul	NULL
of	NULL
each	NULL
,	NULL
were	NULL
coupled	NULL
to	NULL
the	NULL
protein	NULL
A	NULL
beads	NULL
in	NULL
PBS	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

In	NULL
a	NULL
first	NULL
preadsorption	NULL
step	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
protein	NULL
A	NULL
beads	NULL
coupled	NULL
to	NULL
preimmune	NULL
serum	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
.	NULL

These	NULL
immunoprecipitations	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

After	NULL
this	NULL
preadsorption	NULL
the	NULL
supernatants	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
appropriate	NULL
antisera	NULL
for	NULL
2-3	NULL
h.	NULL
When	NULL
using	NULL
anti-peptide	NULL
antisera	NULL
an	NULL
excess	NULL
of	NULL
the	NULL
appropriate	NULL
peptide	NULL
(	NULL
100	NULL
ug	NULL
)	NULL
was	NULL
included	NULL
as	NULL
a	NULL
control	NULL
.	NULL

In	NULL
a	NULL
second	NULL
immunoprecipitation	NULL
the	NULL
samples	NULL
from	NULL
the	NULL
first	NULL
precipitation	NULL
were	NULL
boiled	NULL
in	NULL
1	NULL
%	NULL
SDS	NULL
for	NULL
10	NULL
min	NULL
,	NULL
then	NULL
diluted	NULL
with	NULL
RIPA	NULL
buffer	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
other	NULL
4606	NULL
antibody	NULL
.	NULL

The	NULL
precipitated	NULL
proteins	NULL
,	NULL
coupled	NULL
to	NULL
protein	NULL
A	NULL
beads	NULL
,	NULL
were	NULL
washed	NULL
several	NULL
times	NULL
with	NULL
5	NULL
ml	NULL
ice-cold	NULL
RIPA	NULL
buffer	NULL
,	NULL
boiled	NULL
,	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
and	NULL
exposed	NULL
to	NULL
X-ray	NULL
film	NULL
overnight	NULL
.	NULL

For	NULL
in	NULL
vivo	NULL
labelling	NULL
with	NULL
[	NULL
**Plorthophosphate	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
once	NULL
with	NULL
phosphate-free	NULL
EMEM	NULL
(	NULL
ICN	NULL
)	NULL
and	NULL
subsequently	NULL
incubated	NULL
for	NULL
2	NULL
h	NULL
with	NULL
phosphate-free	NULL
EMEM	NULL
containing	NULL
2	NULL
%	NULL
glutamine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
dialysed	NULL
FCS	NULL
.	NULL

Afterwards	NULL
the	NULL
cells	NULL
were	NULL
labelled	NULL
with	NULL
1	NULL
mCi/	NULL
ml	NULL
for	NULL
45	NULL
min	NULL
and	NULL
subsequently	NULL
induced	NULL
at	NULL
the	NULL
indicated	NULL
times	NULL
.	NULL

Further	NULL
handling	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
for	NULL
[	NULL
*S	NULL
Jmethionine	NULL
labelling	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
Professor	NULL
H.Schuster	NULL
for	NULL
his	NULL
support	NULL
,	NULL
C.Bartsch	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
,	NULL
A.Nieters	NULL
and	NULL
E.N.Hatada	NULL
for	NULL
p100	NULL
and	NULL
p65	NULL
expression	NULL
constructs	NULL
and	NULL
FG	NULL
.	NULL

Wulezyn	NULL
for	NULL
critical	NULL
comments	NULL
on	NULL
the	NULL
manuscript	NULL
.	NULL

This	NULL
project	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
a	NULL
grant	NULL
from	NULL
the	NULL
DFG	NULL
to	NULL
C.S	NULL
.	NULL

(	NULL
Sch-277/3-2	NULL
)	NULL
.	NULL

References	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
,	NULL
63-80	NULL
.	NULL

Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Science	NULL
,	NULL
242	NULL
,	NULL
540-546	NULL
.	NULL

Beg	NULL
,	NULL
A.A.	NULL
and	NULL
Baldwin	NULL
,	NULL
A.S..Jr	NULL
(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
2064-2070	NULL
.	NULL

Beg.A.A	NULL
.	NULL

,	NULL
Ruben	NULL
,	NULL
S.M	NULL
.	NULL

,	NULL
Scheinman	NULL
,	NULL
R.I.	NULL
,	NULL
Haskill	NULL
,	NULL
S.	NULL
,	NULL
Rosen	NULL
,	NULL
C.A	NULL
.	NULL

and	NULL
Baldwin	NULL
,	NULL
A.S..Jr	NULL
(	NULL
1992	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
6	NULL
,	NULL
1899-1913	NULL
.	NULL

Beg	NULL
,	NULL
A.A.	NULL
,	NULL
Finco	NULL
,	NULL
T.S	NULL
.	NULL

,	NULL
Nantermet	NULL
,	NULL
P.V	NULL
.	NULL

and	NULL
Baldwin	NULL
,	NULL
A.S..Jr	NULL
(	NULL
1993	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
3301-3310	NULL
.	NULL

Blank	NULL
,	NULL
V.	NULL
,	NULL
Kourilsky	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Trends	NULL
Biochem	NULL
.	NULL

Sci	NULL
.	NULL

,	NULL
17	NULL
,	NULL
135-140	NULL
.	NULL

Brown	NULL
,	NULL
K.	NULL
,	NULL
Park	NULL
,	NULL
S.	NULL
,	NULL
Kanno	NULL
,	NULL
T.	NULL
,	NULL
Franzoso	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Siebenlist	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
2532-2536	NULL
.	NULL

Chen	NULL
,	NULL
G.	NULL
,	NULL
Pekary	NULL
,	NULL
A.E	NULL
.	NULL

and	NULL
Hershman	NULL
,	NULL
J.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Endocrinology	NULL
,	NULL
131	NULL
,	NULL
863-870	NULL
.	NULL

Cordle	NULL
,	NULL
S.R	NULL
.	NULL

,	NULL
Donald	NULL
,	NULL
R.	NULL
,	NULL
Read	NULL
,	NULL
M.A	NULL
.	NULL

and	NULL
HawigerJ	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
268	NULL
,	NULL
11803-11810	NULL
.	NULL

Dignam	NULL
,	NULL
J.D	NULL
.	NULL

,	NULL
Lebowitz	NULL
,	NULL
R.M	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1983	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
11	NULL
,	NULL
721-732	NULL
.	NULL

Doerre	NULL
,	NULL
S.	NULL
,	NULL
Sista	NULL
,	NULL
P.	NULL
,	NULL
Sun	NULL
,	NULL
$	NULL
.C	NULL
.	NULL

,	NULL
Ballard	NULL
,	NULL
D.W.	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1993	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
10023-10027	NULL
.	NULL

Dressler.K.A	NULL
.	NULL

,	NULL
Mathias	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Kolesnick	NULL
,	NULL
R.N	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Science	NULL
,	NULL
255	NULL
,	NULL
1715-1718.	NULL
de	NULL
Martin	NULL
,	NULL
R.	NULL
,	NULL
Vanhove	NULL
,	NULL
B.	NULL
,	NULL
Cheng	NULL
,	NULL
Q.	NULL
,	NULL
Hofer	NULL
,	NULL
E.	NULL
,	NULL
Csizmadia	NULL
,	NULL
V.	NULL
,	NULL
Winkler	NULL
,	NULL
H	NULL
.	NULL

and	NULL
Bach	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
2773-2779	NULL
.	NULL

Feuillard	NULL
,	NULL
J.	NULL
,	NULL
Gouy	NULL
,	NULL
H.	NULL
,	NULL
Bismuth	NULL
,	NULL
G.	NULL
,	NULL
Lee	NULL
,	NULL
L.M	NULL
.	NULL

,	NULL
Debre	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Korner	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Cytokine	NULL
,	NULL
3	NULL
,	NULL
257-265	NULL
.	NULL

Gerondakis	NULL
,	NULL
S.	NULL
,	NULL
Morrice	NULL
,	NULL
N.	NULL
,	NULL
Richardson	NULL
,	NULL
I.B	NULL
.	NULL

,	NULL
WettenhalL	NULL
,	NULL
R.	NULL
,	NULL
Fecondo	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Grumont.R.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Cell	NULL
Growth	NULL
Diff	NULL
.	NULL

,	NULL
4	NULL
,	NULL
617-627	NULL
.	NULL

Ghosh	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Nature	NULL
,	NULL
344	NULL
,	NULL
678-682	NULL
.	NULL

Griffin	NULL
,	NULL
G.E	NULL
.	NULL

,	NULL
Leung	NULL
,	NULL
K.	NULL
,	NULL
Folks	NULL
,	NULL
Kunkel	NULL
,	NULL
S	NULL
.	NULL

and	NULL
Nabel	NULL
,	NULL
G.J	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Nature	NULL
,	NULL
339	NULL
,	NULL
70-73	NULL
.	NULL

Grilli	NULL
,	NULL
M.	NULL
,	NULL
Chiu	NULL
,	NULL
J.J	NULL
.	NULL

and	NULL
Lenardo	NULL
,	NULL
M.J	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Int	NULL
.	NULL

Rev	NULL
.	NULL

Cytol	NULL
.	NULL

,	NULL
143	NULL
,	NULL
1-62	NULL
.	NULL

Hatada	NULL
,	NULL
E.N	NULL
.	NULL

,	NULL
-	NULL
Nieters	NULL
,	NULL
A.	NULL
,	NULL
-	NULL
Wulezyn	NULL
,	NULL
G.	NULL
,	NULL
-	NULL
Naumann	NULL
,	NULL
M.	NULL
,	NULL
-	NULL
Meyer	NULL
,	NULL
R.	NULL
,	NULL
Nucifora	NULL
,	NULL
G.	NULL
,	NULL
McKeithan	NULL
,	NULL
T.W	NULL
.	NULL

and	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
89	NULL
,	NULL
2489-2493	NULL
.	NULL

Hatada	NULL
,	NULL
E.N	NULL
.	NULL

,	NULL
Naumann	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
2281-2788	NULL
.	NULL

Henkel	NULL
,	NULL
T.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Alkalay	NULL
,	NULL
L	NULL
,	NULL
Kronke	NULL
,	NULL
M.	NULL
,	NULL
Ben-Neriah	NULL
,	NULL
Y	NULL
.	NULL

and	NULL
Bacuerie	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nature	NULL
,	NULL
365	NULL
,	NULL
182-185	NULL
.	NULL

Hohmann	NULL
,	NULL
H.P	NULL
.	NULL

,	NULL
Kolbeck	NULL
,	NULL
R.	NULL
,	NULL
Remy	NULL
,	NULL
R	NULL
.	NULL

and	NULL
van	NULL
Loon	NULL
,	NULL
A.P.G.M	NULL
.	NULL

(	NULL
19912	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
2315-2318	NULL
.	NULL

Hohmann	NULL
,	NULL
H.P	NULL
.	NULL

,	NULL
Remy	NULL
.	NULL

,	NULL
R.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

and	NULL
van	NULL
Loon	NULL
,	NULL
A.P.G.M	NULL
.	NULL

(	NULL
1991b	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
259-266	NULL
.	NULL

Hunter	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
,	NULL
70	NULL
,	NULL
375-387	NULL
.	NULL

Kawakami	NULL
,	NULL
K.	NULL
,	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Roeder	NULL
,	NULL
R.G	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Proc	NULL
.	NULL

Nat	NULL
!	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
85	NULL
,	NULL
4700-4704	NULL
.	NULL

Kerm	NULL
,	NULL
L.D	NULL
.	NULL

,	NULL
Inoue	NULL
,	NULL
J.	NULL
,	NULL
Davis	NULL
,	NULL
N.	NULL
,	NULL
Link	NULL
,	NULL
E.	NULL
,	NULL
Baeuerle	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Bose	NULL
,	NULL
H.R	NULL
.	NULL

,	NULL
Jr	NULL
and	NULL
Verma	NULL
,	NULL
LM	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
5	NULL
,	NULL
1464-1476	NULL
.	NULL

Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Schmidt-Ullrich	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
5043-5049	NULL
.	NULL

Lenardo	NULL
,	NULL
M.J	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Cell	NULL
,	NULL
58	NULL
,	NULL
227-229	NULL
.	NULL

Mellits	NULL
,	NULL
K.H	NULL
.	NULL

,	NULL
Hay	NULL
,	NULL
R.T	NULL
.	NULL

and	NULL
Goodbourn	NULL
,	NULL
$	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

,	NULL
21	NULL
,	NULL
5059-5066	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
Rosette	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
DNA	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
11	NULL
,	NULL
523-537	NULL
.	NULL

Mercurio	NULL
,	NULL
F.	NULL
,	NULL
DiDonato	NULL
.	NULL

J	NULL
.	NULL

A.	NULL
,	NULL
Rosette	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Karin	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
705-718	NULL
.	NULL

Meyer	NULL
,	NULL
R	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
USA	NULL
,	NULL
88	NULL
,	NULL
966-970	NULL
.	NULL

Naumann	NULL
,	NULL
M.	NULL
,	NULL
Wulezyn	NULL
,	NULL
F.G	NULL
.	NULL

and	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1993a	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
213-222	NULL
.	NULL

Naumann	NULL
,	NULL
M.	NULL
,	NULL
Nieters	NULL
,	NULL
A.	NULL
,	NULL
Hatada	NULL
,	NULL
E.N	NULL
.	NULL

and	NULL
Scheidereit	NULL
,	NULL
C	NULL
.	NULL

(	NULL
1993b	NULL
)	NULL
Oncogene	NULL
,	NULL
8	NULL
,	NULL
2275-2281	NULL
.	NULL

Nichols	NULL
,	NULL
M.	NULL
,	NULL
-	NULL
Weih	NULL
,	NULL
F.	NULL
,	NULL
-	NULL
Schmid	NULL
,	NULL
W.	NULL
,	NULL
-	NULL
DeVack	NULL
,	NULL
C.	NULL
,	NULL
_	NULL
Kowenz-Leutz	NULL
,	NULL
E.	NULL
,	NULL
Luckow	NULL
,	NULL
B.	NULL
,	NULL
Boshard	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Schitz.G	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
11	NULL
,	NULL
3337-3346	NULL
.	NULL

Rice	NULL
,	NULL
N.R	NULL
.	NULL

and	NULL
Emst.M.K	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
4685-4695	NULL
.	NULL

Rice	NULL
,	NULL
N.R	NULL
.	NULL

,	NULL
MacKichan	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Israél	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
,	NULL
71	NULL
,	NULL
243-253	NULL
.	NULL

Schmitz	NULL
,	NULL
and	NULL
Baeuerie	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
3805-3817	NULL
.	NULL

Schreck	NULL
,	NULL
R.	NULL
,	NULL
Rieber	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Bacuerle	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
10	NULL
,	NULL
2247-2258	NULL
.	NULL

Schreck.R	NULL
.	NULL

,	NULL
Meier	NULL
,	NULL
B.	NULL
,	NULL
Miannel	NULL
,	NULL
D.	NULL
,	NULL
Droge	NULL
,	NULL
W.	NULL
and	NULL
Bacuerie	NULL
,	NULL
P.A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
175	NULL
,	NULL
1181-1194	NULL
.	NULL

Schiitze	NULL
,	NULL
$	NULL
.	NULL

,	NULL
Potthoff	NULL
,	NULL
K.	NULL
,	NULL
Machleidt	NULL
,	NULL
T.	NULL
,	NULL
Berkovic.D	NULL
.	NULL

,	NULL
Wiegmann.K	NULL
.	NULL

and	NULL
Kronke	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Cell	NULL
,	NULL
71	NULL
,	NULL
765-776	NULL
.	NULL

Schulze-Osthoff.K	NULL
.	NULL

,	NULL
Beyaert	NULL
,	NULL
R.	NULL
,	NULL
Vandevoorde.V..	NULL
Haegeman	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Fiers	NULL
,	NULL
W.	NULL
(	NULL
1993	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
12	NULL
,	NULL
3095-3104	NULL
.	NULL

Scott.M.L	NULL
.	NULL

,	NULL
Fujita	NULL
,	NULL
T.	NULL
,	NULL
Liou	NULL
,	NULL
H.-C.	NULL
,	NULL
Nolan	NULL
,	NULL
G.P	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

,	NULL
7	NULL
,	NULL
1266-1276	NULL
.	NULL

Sen	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Baltimore	NULL
,	NULL
D	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Cell	NULL
,	NULL
47	NULL
,	NULL
921-928	NULL
.	NULL

Shirakawa.F	NULL
.	NULL

and	NULL
Mizel	NULL
,	NULL
$	NULL
.B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
9	NULL
,	NULL
2424-2430	NULL
.	NULL

Staal	NULL
,	NULL
F.J.T	NULL
.	NULL

,	NULL
Roederer	NULL
,	NULL
M.	NULL
,	NULL
Herzenberg	NULL
,	NULL
L.A	NULL
.	NULL

and	NULL
Herzenberg	NULL
,	NULL
L.A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
87	NULL
,	NULL
9943-9947	NULL
.	NULL

Sun	NULL
,	NULL
S.N.-C.	NULL
,	NULL
Ganchi	NULL
,	NULL
P.A	NULL
.	NULL

,	NULL
Ballard	NULL
,	NULL
D.	NULL
W.	NULL
and	NULL
Greene	NULL
,	NULL
W.C.	NULL
(	NULL
1993	NULL
)	NULL
Science	NULL
,	NULL
259	NULL
,	NULL
1912-1915	NULL
.	NULL

Tan	NULL
,	NULL
T.H	NULL
.	NULL

,	NULL
Huang	NULL
,	NULL
G.P	NULL
.	NULL

,	NULL
Sica	NULL
,	NULL
A.	NULL
,	NULL
Ghosh	NULL
,	NULL
P.	NULL
,	NULL
Young	NULL
,	NULL
H.A	NULL
.	NULL

,	NULL
Longo	NULL
,	NULL
D.L	NULL
.	NULL

and	NULL
Rice.N.R	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
12	NULL
,	NULL
4067-4075	NULL
.	NULL

Ten	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Paya	NULL
,	NULL
C.V.	NULL
,	NULL
Israel	NULL
,	NULL
N.	NULL
,	NULL
Le	NULL
Bail	NULL
,	NULL
O.	NULL
,	NULL
Mattei	NULL
,	NULL
M.G	NULL
.	NULL

,	NULL
Virelizier	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Kourilsky	NULL
,	NULL
P	NULL
.	NULL

and	NULL
Israel	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J.	NULL
,	NULL
11	NULL
,	NULL
195-203	NULL
.	NULL

Received	NULL
on	NULL
February	NULL
8	NULL
,	NULL
1994	NULL
;	NULL
revised	NULL
on	NULL
July	NULL
5	NULL
,	NULL
1994	NULL
Mechanism	NULL
of	NULL
NF-xB	NULL
activation	NULL
4607	NULL

